Docstoc

Australian Prescriber - Subject Author Index

Document Sample
Australian Prescriber - Subject  Author Index Powered By Docstoc
					                                            Australian Prescriber
Subject / Author Index                                                                                                     Volumes 29-33
                                                                                                                               2006-2010
                                         This five-year index does not include articles published before 2006
                             For earlier articles, see the online index at www.australianprescriber.com/content/indexing


Subject Index
                                                   acid-base disorders                                - combination analgesics in adults 33(4)
A                                                  - arterial blood gases - abnormal laboratory           113-5
                                                       results 33(4) 124-9                            - - dental notes 33(4) 107
                                                   acne                                               - compatibilities of parenteral drug solutions
abatacept
                                                   - tazarotene - Zorac (New drug) 29(3) 84-7             31(4) 98-101
- rheumatoid arthritis - Orencia (New drug)
                                                   acromegaly                                         - - letter 31(6) 143-5
    30(6) 163-7
                                                   - drug treatment of pituitary tumours 32(1)        - complementary medicines
abnormal laboratory results (see also
                                                       19-21                                          - - AUST R and AUST L numbers -
    diagnostic tests)
                                                   Actemra                                                Medicines Safety Update 33(3) 80-3
- abnormalities in pregnancy 29(2) 48-52
                                                   - see tocilizumab 32(4) 112-5                      - contraceptive failure and etonogestrel
- - letter 29(4) 91-3
                                                   ACTH - see adrenocorticotrophic                        (Implanon)/carbamazepine interactions -
- adrenocortical function in adults 30(6)
                                                       hormone                                            Medicines Safety Update 33(6) 182-5
    147-9
                                                   acute-phase reaction                               - contrast media and 'iodine allergy' 32(5)
- antibodies to cyclic citrullinated peptides
                                                   - C-reactive protein 30(3) 74-6                        125-8
    in rheumatoid arthritis 29(6) 162-4
                                                   adalimumab                                         - - letter 33(3) 64-7
- arterial blood gases 33(4) 124-9
                                                   - in psoriasis 32(1) 14-8                          - corticosteroids
- biochemical tests in pregnancy
                                                   - tumour necrosis factor blockers in               - - corticosteroid-induced osteoporosis and
- - letters 29(1) 3-5
                                                       rheumatology 29(3) 67-70                           fractures 31(2) 45-9
- cell markers 30(5) 128-9
                                                   Addison's disease                                  - cough and cold remedies in children 32(5)
- C-reactive protein 30(3) 74-6
                                                   - abnormal laboratory results 30(6) 147-9              122-4
- magnesium 30(4) 102-5
                                                   ADHD - see attention deficit hyperactivity         - cross-reactivity of penicillins and
- - letter 30(6) 140-1
                                                       disorder                                           cephalosporins 30(1) 25-6
- multiple myeloma screening 32(4) 92-4
                                                   adrenaline                                         - digoxin - brands and dosages 29(6) 153
- pitfalls in interpretation 32(2) 43-6
                                                   - management of anaphylaxis - wallchart            - - letter 30(2) 32-4
- - letter 32(5) 119-121
                                                       30(5) 115                                      - drug interactions with complementary
- point-of-care testing 33(1) 6-9
                                                   - shelf-life of EpiPen (PBAC question) 29(2)           medicines 33(6) 177-80
- - letter 33(6) 167-170
                                                       52-3                                           - - dental notes 33(6) 181
- sexually transmitted infections 30(1) 8-13
                                                   adrenocorticotrophic hormone                       - drug-induced acute akathisia - Medicines
- tests for cell-mediated immunity 33(3)
                                                   - abnormal laboratory results 30(6) 147-9              Safety Update 33(6) 182-5
    84-7
                                                   adverse effects (see also birth defects;           - drugs and road safety 31(2) 33-5
- therapeutic drug monitoring 31(2) 42-4
                                                       drug interactions)                             - ear drops and ototoxicity 31(2) 40-1
- - therapeutic range of digoxin (letter) 31(5)
                                                   - anticonvulsants                                  - exenatide and pancreatitis - Medicines
    115-8
                                                   - - in pregnancy and breastfeeding 31(3)               Safety Update 33(3) 80-3
abnormalities, congenital - see birth
                                                       70-2                                           - fenofibrate-warfarin interactions 29(6) 166
    defects
                                                   - antidepressants in pregnancy and                 - - letter 30(2) 32-4
Aboriginal people
                                                       breastfeeding 30(5) 125-7                      - fish oil and omega-3 fatty acids -
- cardiovascular disease management 33(3)
                                                   - - letter 31(2) 32                                    Medicines Safety Update 33(2) 48-51
    72-5
                                                   - antipsychotic drugs                              - gentamicin toxicity and monitoring
- medication management
                                                   - - in pregnancy and breastfeeding 30(6)               (editorial) 33(5) 134-5
- - letters 29(6) 149-50; 29(3) 59-62
                                                       162-3                                          - gingival bleeding 29(6) 154-5
- subsidised medicines 32(5) 121; 31(4) 89
                                                   - Australian Prescriber and adverse reactions      - headache and analgesic overuse
abortion, therapeutic
                                                       information 33(1) 9                            - - letter 29(3) 59-62
- mifepristone 32(6) 152-4
                                                   - bisphosphonates and osteonecrosis of the         - hypnotics 31(6) 146-9
ACAM2000
                                                       jaw 30(4) 96-7                                 - hyponatraemia
- see vaccinia smallpox vaccine 32(6)
                                                   - - letter 33(6) 167-170                           - - with mirtazapine 31(4) 97
    165-171
                                                   - cabergoline-induced valvulopathy 31(1) 21        - inadequate consumer drug information
acetylcholinesterase inhibitors
                                                   - cephalosporins and penicillin allergy 30(1)          sheets (letter) 31(6) 143-5
- donepezil in Alzheimer's disease (editorial)
                                                       25-6                                           - influenza H1N1 vaccine (editorial) 33(2)
                                                   - cholinesterase inhibitors and syncope -              30-1
- - letter 29(3) 59-62
                                                       Medicines Safety Update 33(5) 156-9            - - letters 33(3) 64-7
                                                   - clindamycin and hepatotoxicity (medicinal        - influenza H1N1 vaccine (Panvax) -
                                                       mishap) 32(5) 140                                  Medicines Safety Update 33(4) 120-3




                                                                         -1-
- interstitial nephritis with omeprazole 30(3)   - - dental notes 29(4) 108                       - patient support organisations -
    67                                           - - letters 30(1) 3-4                                Anaphylaxis Australia 32(5) 128
- label confusion between Atropt and Azopt       Adverse Medicine Events Line                     - penicillins and cephalosporins (medicinal
    (medicinal mishap) 32(5) 138                 - starter packs and adverse effects 30(1)            mishap) 30(1) 25-6
- lamotrigine and serious skin reactions -           14-6                                         - safe use of radiographic contrast media
    Medicines Safety Update 33(6) 182-5          advertising                                          33(1) 19-22
- Medicines Safety Update 33(1) 10-11            - complementary medicines (letter) 30(6)         - - letter 33(3) 64-7
- metformin in pregnancy and lactation               140-1                                        - sulfonamide allergy and cross-reactivity
    30(3) 68-9                                   - direct-to-consumer advertising                     31(1) 8-10
- mirtazapine-induced hyponatraemia              - - in New Zealand 29(2) 30-2                    - - letters 31(4) 88-9
    (medicinal mishap) 31(4) 97                  - drug industry and quality use of medicines     alpha blockers
- - letter 32(1) 5                                   (editorials) 33(4) 98-9; 33(4) 99-100        - alfuzosin - benign prostatic hyperplasia -
- morphine dosages in acute pain (medicinal      - drug industry payments to health                   Xatral SR (New drug) 33(2) 52-9
    mishap) 32(1) 13                                 professionals (editorial) 33(5) 136-7        alpha fetoprotein
- neurocognitive effects of chemotherapy         - drug marketing and the internet 32(1) 2-4      - biochemical tests for abnormalities in
    31(1) 22-4                                   - drug promotion and health professionals            pregnancy 29(2) 48-52
- neutropenia with quetiapine 31(1) 10-1             (letters) 31(3) 60-2                         alpha-1-antitrypsin deficiency
- NSAIDS and cardiovascular disease in           - efficacy of Ginkgo biloba in tinnitus          - chronic obstructive pulmonary disease
    rheumatology (editorial) 29(4) 90-1              (letter) 30(2) 32-4                              (letter) 30(6) 140-1
- omeprazole and interstitial nephritis 30(3)    - Medicines Australia - code of conduct          alternative medicines - see complementary
    67                                               breaches 33(6) 176; 32(6) 160-1; 31(6)           medicines
- osteonecrosis of the jaw with                      162-3; 30(6) 153-5; 29(6) 164-5; 29(1)       Alzheimer's disease and dementia
    bisphosphonates 30(4) 96-7                       16-7                                         - cholinesterase inhibitors and syncope -
- overdoses of over-the-counter Donnalix         - - letter 33(4) 101-2                               Medicines Safety Update 33(5) 156-9
    Infant Drops 29(3) 83                        - - vardenafil 30(6) 154                         - donepezil (editorial)
- paracetamol, gastrointestinal bleeding and     - regulation of complementary medicines          - - letter 29(3) 59-62
    hypertension (letter) 30(3) 59-63                (editorial) 31(6) 142-3                      - management 32(1) 9-12
- polypharmacy (editorial) 31(1) 2-3             aged                                             ambrisentan
- radiographic contrast media 33(1) 19-22        - beta blockers in hypertension 30(1) 5-7        - pulmonary arterial hypertension - Volibris
- - letter 33(3) 64-7                            - polypharmacy (editorial) 31(1) 2-3                 (New drug) 33(1) 22-7
- salmeterol (editorial) 29(5) 118-9             agomelatine                                      aminoglycosides
- serotonin syndrome                             - Valdoxan - major depression (New drug)         - ear drops and ototoxicity 31(2) 40-1
- - Medicines Safety Update 33(6) 182-5              33(5) 160-3                                  - gentamicin toxicity and monitoring
- - over-the-counter dextromethorphan 29(3)      AIDS - see HIV/AIDS                                  (editorial) 33(5) 134-5
    71                                           akathisia                                        amlodipine
- - - letter 29(6) 149-50                        - drug-induced acute akathisia - Medicines       - with valsartan - hypertension - Exforge
- sibutramine - obesity - Medicines Safety           Safety Update 33(6) 182-5                        (New drug) 32(1) 22-7
    Update 33(3) 80-3                            alcohol                                          amoxycillin
- starter packs and drug samples 30(1) 14-6      - lifestyle management of hypertension           - dental infections (letter) 33(5) 137
- statins, macrolides and rhabdomyolysis -           31(6) 150-3                                  amphetamines
    Medicines Safety Update 33(5) 156-9          aldosterone                                      - adverse effects 29(4) 109-11
- sulfonamide allergy and cross-reactivity       - abnormal laboratory results 30(6) 147-9        anaemia
    31(1) 8-10                                   Aldurazyme                                       - epoetin beta - recombinant erythropoietin -
- - letters 32(2) 31; 31(4) 88-9                 - see laronidase 30(3) 79-82                         Neorecormon (New drug) 29(4) 112-5
- tamsulosin and floppy iris syndrome -          alemtuzumab                                      - management in chronic kidney disease
    medicinal mishap 33(3) 88-9                  - chronic lymphocytic leukaemia -                    31(6) 154-8
- thiazolidinediones                                 MabCampath (New drug) 29(6) 167-71           - management of uraemic and iron
- - in diabetes (editorial) 31(3) 58-9           alfuzosin                                            deficiency anaemia in chronic kidney
- toxicity with Donnalix Infant Drops 29(3)      - benign prostatic hyperplasia - Xatral SR           disease 32(5) 129-131
    83                                               (New drug) 33(2) 52-9                        - methoxy polyethylene glycol-epoetin beta
- treatment of perinatal depression 31(2)        alglucosidase alfa                                   - chronic kidney disease - Mircera (New
    36-9                                         - Pompe disease - Myozyme (New drug)                 drug) 32(6) 165-171
- tumour necrosis factor blockers - risk of          31(3) 79-83                                  anaemia, aplastic
    malignancy (letter) 31(3) 60-2               aliskiren                                        - antithymocyte globulin - Thymocyte (New
- uterine perforation and                        - in hypertension 32(5) 135-8                        drug) 31(5) 136-9
    levonorgestrel-releasing intrauterine        - - letter 33(3) 64-7                            anaemia, haemolytic
    system - Medicines Safety Update 33(5)       - pharmacology of renin inhibitors 32(5)         - eculizumab - paroxysmal nocturnal
    156-9                                            132-5                                            haemoglobinuria - Soliris (New drug)
- varenicline (Champix) and psychiatric          allergy                                              32(4) 112-5
    symptoms - Medicines Safety Update           - contrast media, seafood and 'iodine allergy'   anaesthetics
    33(4) 120-3                                      32(5) 125-8                                  - managing painful paediatric procedures
- xerostomia, drugs and radiotherapy 29(4)       - - letter 33(3) 64-7                                29(4) 94-6
    97-8                                         - monoclonal antibodies 29(5) 130-3              - - dental notes 29(4) 108




                                                                      -2-
- - letters 29(6) 149-50                         angiography                                     - in management of pertussis in adults 32(2)
- sugammadex - reversal of neuromuscular         - magnetic resonance imaging in                     36-8
    blockade by rocuronium or vecuronium -           neuroradiology 31(1) 18-20                  - otitis media management in children 32(6)
    Bridion (New drug) 32(3) 82-6                angiotensin converting enzyme inhibitors -          155-9
analgesia                                            see ACE inhibitors                          - resistance
- lumiracoxib - Prexige (New drug) 29(1)         angiotensin receptor antagonists                - - community-acquired methicillin-resistant
    25-7                                         - amlodipine with valsartan - Exforge (New          Staphylococcus aureus infection
- managing acute pain in opioid dependence           drug) 32(1) 22-7                            - - - letter 29(3) 59-62
    31(5) 133-5                                  - olmesartan medoxomil - Olmetec (New           - - multiresistant organisms 33(3) 68-71
- morphine dosages in acute pain (medicinal          drug) 30(3) 79-82                           - - - dental notes 33(3) 71
    mishap) 32(1) 13                             - valsartan - Diovan (New drug) 32(1) 22-7      - - - - letters 33(6) 167-170; 33(5) 137
- paediatric analgesia 31(3) 63-5                - valsartan with hydrochlorothiazide -          - - rifampicin and MRSA infections (PBAC
- - letters 31(6) 143-5                              Co-Diovan (New drug) 32(1) 22-7                 question) 33(5) 145-6
analgesics (see also anti-inflammatory           anidulafungin                                   - - rifampicin and MRSA infections -
    drugs)                                       - invasive candidiasis - Eraxis (New drug)          Orphan Drug Scheme (letter) 29(1) 3-5
- combination analgesics in adults 33(4)             32(6) 165-171                               - statins, macrolides and rhabdomyolysis -
    113-5                                        anti-inflammatory drugs (see also                   Medicines Safety Update 33(5) 156-9
- - dental notes 33(4) 107                           analgesics)                                 - sulfonamide allergy and cross-reactivity
- etoricoxib - Arcoxia (New drug) 32(5)          - combination NSAIDS and opioids 33(4)              31(1) 8-10
    142-5                                            113-5                                       - - letters 32(2) 31; 31(4) 88-9
- headache and analgesic overuse                 - dental and oral pain, management 30(3)        - Therapeutic Guidelines: Antibiotic - book
- - letter 29(3) 59-62                               77-9                                            reviews 30(3) 73
- lumiracoxib - Prexige (New drug) 29(1)         - NSAIDs                                        - tigecycline - complicated infections -
    25-7                                         - - and cardiovascular disease in                   Tygacil (New drug) 29(5) 138-43
- methylnaltrexone bromide - opioid                  rheumatology (editorial) 29(4) 90-1         antibodies, monoclonal - see monoclonal
    analgesic-induced constipation - Relistor    - - in paediatric analgesia 31(3) 63-5              antibodies
    (New drug) 32(1) 22-7                        anti-thymocyte globulin                         anticancer drugs - see antineoplastics
- Therapeutic Guidelines - book review           - kidney transplantation and aplastic           anticholinergic drugs
    31(2) 39                                         anaemia - Thymoglobuline (New drug)         - darifenacin hydrobromide - overactive
anaphylaxis                                          31(5) 136-9                                     bladder - Enablex (New drug) 29(5)
- contrast media, seafood and 'iodine allergy'   antiandrogens                                       138-43
    32(5) 125-8                                  - degarelix - prostate cancer - Firmagon        - overactive bladder 29(1) 22-4
- - letter 33(3) 64-7                                (New drug) 33(6) 193-8                      - - letter 29(4) 91-3
- patient support organisation 32(5) 128         - triptorelin embonate - prostate cancer -      - overdoses in infantile colic 29(3) 83
- wallchart - Emergency management of                Diphereline (New drug) 32(1) 22-7           - solifenacin succinate - overactive bladder -
    anaphylaxis in the community 2007 30(5)      antiarrhythmic drugs - see arrhythmia               Vesicare (New drug) 29(5) 138-43
    115                                          antibiotics                                     - toxicity with Donnalix Infant Drops
anecortave                                       - antibiotic guidelines and endocarditis            (medicinal mishap) 29(3) 83
- macular degeneration - Retaane (New            - - dental notes 31(6) 153                      anticholinesterase - see cholinesterase
    drug) 29(2) 53-5                             - in bronchiectasis 31(3) 77-9                      inhibitors
angina (see also coronary disease)               - - letter 31(5) 115-8                          anticoagulants
- ivabradine - Corolan (New drug) 30(2)          - cephalosporins and penicillin allergy 30(1)   - dabigatran etexilate - prevention of
    50-5                                             25-6                                            postoperative venous thrombosis -
angioedema                                       - clindamycin and hepatotoxicity (medicinal         Pradaxa (New drug) 32(2) 51-5
- hereditary                                         mishap) 32(5) 140                           - gingival bleeding 29(6) 154-5
- - human C1 esterase inhibitor - Berinert       - cross-reactivity of penicillins and           - heparins in venous thromboembolism
    (New drug) 33(3) 89-95                           cephalosporins (medicinal mishap) 30(1)         prophylaxis 32(4) 108-12
- - icatibant - Firazyr (New drug) 33(6)             25-6                                        - - letter 33(6) 167-170
    193-8                                        - daptomycin - skin infections,                 - human protein C - Ceprotin - congenital
angiogenesis inhibitors                              Staphylococcus aureus bacteraemia -             protein C deficiency (New drug) 30(2)
- in cancer - clinical applications 29(1) 13-5       Cubicin (New drug) 32(2) 51-5                   50-5
- in cancer - pharmacology 29(1) 9-12            - dental and oral pain, management 30(3)        - new oral anticoagulants in hip and knee
- erlotinib - non-small cell lung cancer -           77-9                                            arthroplasty 33(2) 42-7
    Tarceva (New drug) 29(2) 53-5                - doripenem - specified infections - Doribax    - - letter 33(6) 167-170
- pazopanib - metastatic renal cell carcinoma        (New drug) 32(3) 82-6                       - pharmacology of new oral anticoagulants
    - Votrient (New drug) 33(6) 193-8            - ear drops and ototoxicity 31(2) 40-1              33(2) 38-41
- renal cell cancer 29(6) 151-3                  - foot infections in diabetes 30(1) 21-4        - rivaroxaban (Xarelto) adverse events -
- sorafenib - renal cell cancer - Nexavar        - gentamicin toxicity and monitoring                Medicines Safety Update 33(5) 156-9
    (New drug) 29(6) 167-71                          (editorial) 33(5) 134-5                     - rivaroxaban - prevention of postoperative
- sunitinib - gastrointestinal stromal tumour,   - management of animal and human bites              venous thrombosis - Xarelto (New drug)
    renal cell cancer - Sutent (New drug)            29(1) 6-8                                       32(1) 22-7
    29(6) 167-71                                 - - letters 29(3) 59-62                         - warfarin
                                                                                                 - - bioequivalence of Marevan and
                                                                                                     Coumadin




                                                                      -3-
- - - letters 30(2) 32-4                       - renin inhibitors 32(5) 135-8                  - pazopanib - metastatic renal cell carcinoma
- - interactions with fenofibrate 29(6) 166    - - letter 33(3) 64-7                               - Votrient (New drug) 33(6) 193-8
- - - letter 30(2) 32-4                        - valsartan - Diovan (New drug) 32(1) 22-7      - plerixafor - lymphoma, multiple myeloma
- - pharmacogenetic testing 32(3) 76-80        - valsartan with hydrochlorothiazide -              - Mozobil (New drug) 33(5) 160-3
- - - dental notes 32(3) 80                        Co-Diovan (New drug) 32(1) 22-7             - renal cell cancer 29(6) 151-3
- - - letter 32(5) 119-121                     antileukotriene drugs - see leukotriene         - sorafenib - Nexavar - renal cell cancer
anticonvulsants (see also epilepsy)                receptor antagonists                            (New drug) 29(6) 167-71
- in bipolar disorders 30(3) 70-3              antilipidaemic drugs                            - sunitinib - Sutent - gastrointestinal stromal
- lacosamide - partial-onset epileptic         - fenofibrate                                       tumour, renal cell cancer (New drug)
    seizures - Vimpat (New drug) 33(1) 22-7    - - interactions with warfarin 29(6) 166            29(6) 167-71
- in neuropathic pain 29(3) 72-5               - - - letter 30(2) 32-4                         - taxanes and breast cancer (PBAC question)
- in pregnancy and breastfeeding 31(3) 70-2    - management of hypercholesterolaemia               30(1) 24-5
- withdrawal of drugs in seizure-free              31(5) 119-22                                - temsirolimus - Torisel - renal cell
    children 29(1) 18-21                       - omega-3-acid ethyl esters -                       carcinoma (New drug) 31(4) 108-11
antidepressant drugs                               hypertriglyceridaemia, secondary            antipsychotics
- acute management of bipolar disorders            prevention following myocardial             - in bipolar disorders 30(3) 70-3
    31(3) 73-6                                     infarction - Omacor (New drug) 33(6)        - drug-induced acute akathisia - Medicines
- - letter 31(5) 115-8                             193-8                                           Safety Update 33(6) 182-5
- agomelatine - major depression - Valdoxan    - rosuvastatin - hypercholesterolaemia -        - long-term community management of
    (New drug) 33(5) 160-3                         Crestor (New drug) 29(6) 167-71                 psychotic disorders 30(2) 44-6
- depression in medical illness 30(4) 86-8     - statins, macrolides and rhabdomyolysis -      - neutropenia with quetiapine (medicinal
- desvenlafaxine - Pristiq (New drug) 32(1)        Medicines Safety Update 33(5) 156-9             mishap) 31(1) 10-1
    22-7                                       antimalarials - see malaria                     - paliperidone - schizophrenia - Invega (New
- duloxetine - major depression - Cymbalta     antineoplastics                                     drug) 31(2) 49-55
    (New drug) 31(3) 79-83                     - alemtuzumab - MabCampath - chronic            - in pregnancy and breastfeeding 30(6)
- mirtazapine-induced hyponatraemia                lymphocytic leukaemia (New drug) 29(6)          162-3
    (medicinal mishap) 31(4) 97                    167-71                                      - ziprasidone - Zeldox (New drug) 30(2)
- - letter 32(1) 5                             - angiogenesis inhibitors in cancer 29(1)           50-5
- neuropathic pain 29(3) 72-5                      9-12; 29(1) 13-5                            - - letter 30(3) 59-63
- pregnancy and breastfeeding 30(5) 125-7      - arsenic trioxide - acute promyelocytic        antiretroviral drugs (see also antiviral
- - letter 31(2) 32                                leukaemia - Phenasen (New drug) 32(5)           drugs)
- suicide risk in children (editorials)            142-5                                       - darunavir - HIV - Prezista (New drug)
- - letter 29(2) 32-5                          - azacitidine - myelodysplasia, leukaemia -         30(3) 79-82
- treatment of perinatal depression 31(2)          Vidaza (New drug) 33(3) 89-95               - etravirine - HIV - Intelence (New drug)
    36-9                                       - bortezomib - multiple myeloma - Velcade           32(2) 51-5
antiepileptics - see anticonvulsants               (New drug) 29(3) 84-7                       - HIV fusion inhibitors - pharmacology
antifungal drugs                               - chemotherapy and cancer survival rates            31(3) 66-9
- anidulafungin - invasive candidiasis -           (editorial) 29(1) 2-3                       - maraviroc - HIV - Celsentri (New drug)
    Eraxis (New drug) 32(6) 165-171            - clofarabine - paediatric acute lymphocytic        31(6) 165-7
- butoconazole nitrate - candidal                  leukaemia - Evoltra (New drug) 33(2)        - raltegravir - HIV - Isentress (New drug)
    vulvovaginitis - Gynazole (New drug)           52-9                                            31(2) 49-55
    29(5) 138-43                               - dasatinib - Sprycel - chronic myeloid and     - tipranavir - HIV - Aptivus (New drug)
- posaconazole - Noxafil (New drug) 29(3)          acute lymphoblastic leukaemia (New              30(4) 107-11
    84-7                                           drug) 30(2) 50-5                            antivenoms
antihistamines - see histamine                 - erlotinib - Tarceva - non-small cell lung     - management of injuries by sea creatures
antihypertensives                                  cancer (New drug) 29(2) 53-5                    30(5) 117-21
- beta blockers 30(1) 5-7                      - fosaprepitant - Emend IV - emetogenic         - - letter 31(2) 32
- - letter 30(3) 59-63                             cancer chemotherapy (New drug) 31(4)        - snake bites 29(5) 125-9
- drug treatment of elevated blood pressure        108-11                                      - spider bites 29(6) 156-8
    33(4) 108-12                               - fulvestrant - breast cancer - Faslodex (New   antiviral drugs (see also antiretroviral
- eplerenone - heart failure post-myocardial       drug) 30(4) 107-11                              drugs)
    infarction - Inspra (New drug)             - lapatinib - breast cancer - Tykerb (New       - entecavir - chronic hepatitis B - Baraclude
- - letter 29(2) 32-5                              drug) 30(5) 133-5                               (New drug) 29(5) 138-43
- moxonidine - Physiotens (New drug) 29(1)     - lenalidomide - multiple myeloma -             - etravirine - HIV - Intelence (New drug)
    25-7                                           Revlimid (New drug) 31(2) 49-55                 32(2) 51-5
- nebivolol - hypertension, chronic heart      - leukaemia in adults 29(3) 76-9                - hepatitis B 32(4) 99-104
    failure - Nebilet (New drug) 33(2) 52-9    - neurocognitive effects of chemotherapy        - hepatitis C 29(2) 36-9
- - correction 33(4) 131                           31(1) 22-4                                  - influenza prophylaxis (editorial) 30(2)
- - letter 33(4) 101-2                         - nilotinib - chronic myeloid leukaemia -           30-1
- olmesartan medoxomil - Olmetec (New              Tasigna (New drug) 31(2) 49-55              - telbivudine - chronic hepatitis B - Sebivo
    drug) 30(3) 79-82                          - panitumumab - Vectibix - metastatic               (New drug) 30(6) 163-7
- pharmacology of renin inhibitors 32(5)           colorectal cancer (New drug) 31(5) 136-9
    132-5




                                                                    -4-
Apidra SoloStar                                   Australian Prescriber                             Berinert
- see insulin glulisine 30(5) 133-5               - 30th anniversary and history                    - see human C1 esterase inhibitor 33(3)
APMA - see Australian Pharmaceutical              - - letter 29(2) 32-5                                 89-95
    Manufacturers Association                     - adverse reactions information 33(1) 9           beta agonists
apnoea                                            - declarations of conflict of interest (letter)   - indacaterol - chronic obstructive
- caffeine citrate - apnoea of prematurity -          29(4) 91-3                                        pulmonary disease - Onbrez Breezhaler
    Cafnea (New drug) 33(3) 89-95                 - information from the drug industry about            (New drug) 33(5) 160-3
Aptivus                                               new drugs                                     - salmeterol - safety concerns (editorial)
- see tipranavir 30(4) 107-11                     - - letter 29(3) 59-62                                29(5) 118-9
arachnidism                                       - transparency of new drug information            beta blockers
- management 29(6) 156-8                              32(3) 80-1; 30(1) 26-7                        - hypertension 30(1) 5-7
Arcoxia                                           - website user surveys 30(1) 16                   - - letter 30(3) 59-63
- see etoricoxib 32(5) 142-5                      autoimmune diseases                               - nebivolol - hypertension, chronic heart
arsenic trioxide                                  - antibodies to cyclic citrullinated peptides         failure - Nebilet (New drug) 33(2) 52-9
- acute promyelocytic leukaemia - Phenasen            in rheumatoid arthritis 29(6) 162-4           - - correction 33(4) 131
    (New drug) 32(5) 142-5                        - immunosuppressants 29(4) 102-8                  - - letter 33(4) 101-2
arthritis (see also osteoarthritis;               - long-term management of patients taking         bevacizumab
    rheumatology)                                     immunosuppressants 32(3) 68-71                - angiogenesis inhibitors in cancer 29(1)
- golimumab - rheumatoid arthritis, psoriatic     - - dental notes 32(3) 75                             9-12; 29(1) 13-5
    arthritis, ankylosing spondylitis - Simponi   - monoclonal antibodies 29(5) 130-3               - in renal cell cancer 29(6) 151-3
    (New drug) 33(1) 22-7                         - myasthenia gravis 30(6) 156-60                  bioavailability
- NSAIDs and cardiovascular disease               avian influenza                                   - meals and medicines 29(2) 40-2
    (editorial) 29(4) 90-1                        - antiviral drugs and vaccination (editorial)     bioequivalence
- rheumatoid                                          30(2) 30-1                                    - biosimilars are not (bio)generics (editorial)
- - abatacept - Orencia (New drug) 30(6)          aviation - see travel                                 32(6) 146-7
    163-7                                         Avodart                                           - - letter 33(2) 32-3
- - abnormal laboratory results - antibodies      - see dutasteride 32(4) 112-5                     - generic drugs 30(2) 41-3
    to cyclic citrullinated peptides 29(6)        azacitidine                                       - - letter 30(4) 88-90
    162-4                                         - Vidaza - myelodysplasia, leukaemia (New         - Marevan and Coumadin (letter) 30(2) 32-4
- - tumour necrosis factor blockers 29(3)             drug) 33(3) 89-95                             - prescription drug pricing 32(1) 6-8
    67-70                                         azathioprine                                      biological products (see also monoclonal
- - - risk of malignancy (letter) 31(3) 60-2      - in myasthenia gravis 30(6) 156-60                   antibodies and specific drugs)
aspirin                                           - pharmacology of immunosuppressants              - bioequivalence of biosimilars (editorial)
- antiplatelet therapy after coronary stents          29(4) 99-101                                      32(6) 146-7
    30(4) 92-6                                    Azopt                                             - - letter 33(2) 32-3
- combination analgesics in adults 33(4)          - see brinzolamide 32(5) 138                      bipolar disorders
    113-5                                                                                           - acute management 31(3) 73-6
asthma                                            B                                                 - - letter 31(5) 115-8
- salmeterol - safety concerns (editorial)                                                          - bipolar I - ziprasidone - Zeldox (New drug)
    29(5) 118-9                                                                                         30(2) 50-5
                                                  bacteraemia
- starting corticosteroid therapy 29(3) 63-6                                                        - - letter 30(3) 59-63
                                                  - daptomycin - Staphylococcus aureus
atenolol                                                                                            - drug therapy 30(3) 70-3
                                                      bacteraemia - Cubicin (New drug) 32(2)
- beta blockers in hypertension 30(1) 5-7                                                           birth defects
                                                      51-5
- - letter 30(3) 59-63                                                                              - anticonvulsants in pregnancy and
                                                  balsalazide
atomoxetine                                                                                             breastfeeding 31(3) 70-2
                                                  - ulcerative colitis - Colazide (New drug)
- in attention deficit hyperactivity disorder                                                       - antidepressants in pregnancy 30(5) 125-7
                                                  - - letter 29(2) 32-5
    31(5) 129-32                                                                                    - - letter 31(2) 32
                                                  Baraclude
atropine                                                                                            - biochemical tests in pregnancy 29(2) 48-52
                                                  - see entecavir 29(5) 138-43
- label confusion between Atropt and Azopt                                                          - metformin in pregnancy and lactation
                                                  beclomethasone dipropionate
    (medicinal mishap) 32(5) 138                                                                        30(3) 68-9
                                                  - corticosteroid therapy in asthma 29(3) 63-6
Atropt                                                                                              bisphosphonates
                                                  behaviour disorders
- see atropine 32(5) 138                                                                            - ibandronic acid - hypercalcaemia, bony
                                                  - attention deficit hyperactivity disorder
attention deficit hyperactivity disorder                                                                metastases of breast cancer - Bondronat
                                                  - - management 31(5) 129-32
- management 31(5) 129-32                                                                               (New drug) 31(3) 79-83
                                                  - - methylphenidate (PBAC question) 31(3)
- methylphenidate (PBAC questions) 31(3)                                                            - and osteonecrosis of the jaws 30(4) 96-7
                                                      76
    76                                                                                              - - letter 33(6) 167-170
                                                  Bence-Jones protein
AusPharm Consumer Health Watch                                                                      - prevention of corticosteroid-induced bone
                                                  - multiple myeloma screening 32(4) 92-4
- publishing of drug evaluations (editorial)                                                            loss 31(2) 45-9
                                                  benzodiazepines
    29(5) 120                                                                                       bites and stings
                                                  - drugs and road safety 31(2) 33-5
- - letter 30(2) 32-4                                                                               - management of animal and human bites
                                                  - in insomnia
                                                                                                        29(1) 6-8
                                                  - - comparisons with zolpidem and
                                                                                                    - - letters 29(3) 59-62
                                                      zopiclone 31(6) 146-9
                                                                                                    - sea creatures 30(5) 117-21




                                                                        -5-
- - letter 31(2) 32                            brinzolamide                                    - - letters 30(1) 3-4
- snake bites 29(5) 125-9                      - label confusion between Atropt and Azopt      - tumour necrosis factor blockers - risk of
- spider bites 29(6) 156-8                         (medicinal mishap) 32(5) 138                    malignancy (letter) 31(3) 60-2
bladder, overactive                            bronchiectasis                                  - tumour-induced hypercalcaemia -
- anticholinergic drugs 29(1) 22-4             - management 31(3) 77-9                             ibandronic acid - Bondronat (New drug)
- - letter 29(4) 91-3                          - - letter 31(5) 115-8                              31(3) 79-83
- darifenacin hydrobromide - Enablex (New      bronchodilators                                 cancer chemotherapy - see antineoplastics
    drug) 29(5) 138-43                         - in chronic obstructive pulmonary disease      candidiasis
- solifenacin succinate - Vesicare - (New          30(3) 64-7                                  - anidulafungin - invasive candidiasis -
    drug) 29(5) 138-43                         - - letter - alpha-1-antitrypsin deficiency         Eraxis (New drug) 32(6) 165-171
blood coagulation factors                          30(6) 140-1                                 - butoconazole nitrate - candidal
- factor VIII inhibitor bypassing fraction -   - indacaterol - chronic obstructive                 vulvovaginitis - Gynazole (New drug)
    haemophilia - FEIBA-NF (New drug)              pulmonary disease - Onbrez Breezhaler           29(5) 138-43
    30(2) 50-5                                     (New drug) 33(5) 160-3                      carbamazepine
blood donation                                 bruxism                                         - in bipolar disorders 30(3) 70-3
- safety of plasma-derived products 33(3)      - psychotropic drugs and dentistry 30(4)        - contraceptive failure and etonogestrel
    76-9                                           98-101                                          (Implanon)/carbamazepine interactions -
blood gas analysis                             budesonide                                          Medicines Safety Update 33(6) 182-5
- abnormal laboratory results 33(4) 124-9      - corticosteroid therapy in asthma 29(3) 63-6   carbapenem antibiotics
blood pressure - see antihypertensives;        butoconazole nitrate                            - doripenem - specified infections - Doribax
    hypertension                               - candidal vulvovaginitis - Gynazole (New           (New drug) 32(3) 82-6
blood volume                                       drug) 29(5) 138-43                          carbetocin
- pentastarch - hypovolaemia - Voluven         Byetta                                          - prevention of uterine atony after caesarian
    (New drug) 30(4) 107-11                    - see exenatide 30(6) 163-7                         section - Duratocin (New drug) 30(4)
Bondronat                                                                                          107-11
- see ibandronic acid 31(3) 79-83              C                                               carcinoma, renal cell - see renal cell
bone diseases                                                                                      carcinoma
- management in kidney disease 33(2) 34-7                                                      cardiovascular diseases
                                               C-reactive protein
bone fractures                                                                                 - diabetes
                                               - abnormal laboratory results 30(3) 74-6
- corticosteroid-induced 31(2) 45-9                                                            - - exercise 30(5) 130-3
                                               cabergoline
Bordetella pertussis infection - see                                                           - - glucose control (editorial) 32(2) 30-1
                                               - cabergoline-induced valvulopathy
    pertussis                                                                                  - drug treatment of elevated blood pressure
                                                   (medicinal mishap) 31(1) 21
bortezomib                                                                                         33(4) 108-12
                                               caesarian section
- multiple myeloma - Velcade (New drug)                                                        - echocardiography 29(5) 134-8
                                               - carbetocin - prevention of uterine atony -
    29(3) 84-7                                                                                 - - letter 30(1) 3-4
                                                   Duratocin (New drug) 30(4) 107-11
- new drugs for multiple myeloma 32(4)                                                         - endocarditis - dental notes 31(6) 153
                                               caffeine
    95-8                                                                                       - hypertension management 31(6) 150-3
                                               - caffeine citrate - Cafnea - apnoea of
botulinum toxin                                                                                - management in Aboriginal people 33(3)
                                                   prematurity (New drug) 33(3) 89-95
- clinical use 32(2) 39-42                                                                         72-5
                                               Cafnea
brain                                                                                          - managing risk in chronic kidney disease
                                               - see caffeine citrate 33(3) 89-95
- magnetic resonance imaging in                                                                    31(6) 154-8
                                               calcineurin inhibitors
    neuroradiology 31(1) 18-20                                                                 - NSAIDs in rheumatology (editorial) 29(4)
                                               - management of patients taking
breast cancer                                                                                      90-1
                                                   immunosuppressants 32(3) 68-71
- fulvestrant - Faslodex (New drug) 30(4)                                                      - Therapeutic Guidelines - book reviews
                                               - pharmacology of immunosuppressants
    107-11                                                                                         31(6) 158
                                                   29(4) 99-101; 29(4) 102-8
- ibandronic acid - hypercalcaemia, bony                                                       - thiazolidinedione adverse effects in
                                               calcitriol
    metastases of breast cancer - Bondronat                                                        diabetes (editorial) 31(3) 58-9
                                               - vitamin D deficiency in adults 33(4) 103-6
    (New drug) 31(3) 79-83                                                                     - undertreatment in rural populations
                                               calcium supplementation
- lapatinib - Tykerb (New drug) 30(5) 133-5                                                        (editorial) 31(4) 86-7
                                               - prevention of corticosteroid-induced bone
- taxanes (PBAC question) 30(1) 24-5                                                           cataract surgery
                                                   loss 31(2) 45-9
breastfeeding                                                                                  - tamsulosin and floppy iris syndrome -
                                               cancer (see also antineoplastics and
- anticonvulsants 31(3) 70-2                                                                       medicinal mishap 33(3) 88-9
                                                   specific organs)
- antidepressants 30(5) 125-7                                                                  cell markers
                                               - angiogenesis inhibitors - pharmacology
- - letter 31(2) 32                                                                            - abnormal laboratory results 30(5) 128-9
                                                   29(1) 9-12; 29(1) 13-5
- antipsychotics 30(6) 162-3                                                                   Celsentri
                                               - chemotherapy and cancer survival rates
- metformin and diabetes 30(3) 68-9                                                            - see maraviroc 31(6) 165-7
                                                   (editorial) 29(1) 2-3
- treatment of perinatal depression 31(2)                                                      cephalosporins
                                               - melanoma - diagnostic tests 33(5) 150-5
    36-9                                                                                       - penicillin allergy 30(1) 25-6
                                               - neurocognitive effects of chemotherapy
Bridion                                                                                        Ceprotin
                                                   31(1) 22-4
- see sugammadex 32(3) 82-6                                                                    - see protein C 30(2) 50-5
                                               - positron emission tomography 31(5) 123-8
                                               - radiotherapy and xerostomia 29(4) 97-8
                                               - - dental notes 29(4) 108




                                                                    -6-
cerebrovascular disorders                         cholecalciferol                                 cognitive behaviour therapy
- beta blockers in hypertension 30(1) 5-7         - vitamin D deficiency in adults 33(4) 103-6    - depression in medical illness 30(4) 86-8
- - letter 30(3) 59-63                            cholinesterase inhibitors                       Colazide
- magnetic resonance imaging in                   - dementia 32(1) 9-12                           - see balsalazide 29(2) 32-5
    neuroradiology 31(1) 18-20                    - and syncope - Medicines Safety Update         colic, infantile
certolizumab                                         33(5) 156-9                                  - overdoses of over-the-counter
- Cimzia - rheumatoid arthritis (New drug)        chronic obstructive pulmonary disease -             anticholinergic drugs 29(3) 83
    33(4) 129-131                                    see pulmonary disease                        colitis, ulcerative
Cervarix                                          ciclesonide                                     - balsalazide - Colazide (New drug)
- human papillomavirus vaccine 30(5) 133-5        - corticosteroid therapy in asthma 29(3) 63-6   - - letter 29(2) 32-5
cervical cancer                                   cilostazol                                      colorectal cancer
- human papillomavirus vaccine - Cervarix         - intermittent claudication - Pletal (New       - angiogenesis inhibitors 29(1) 13-5
    (New drug) 30(5) 133-5                           drug) 32(3) 82-6                             - panitumumab - Vectibix (New drug) 31(5)
- human papillomavirus vaccine - Gardasil         Cimzia                                              136-9
    (New drug) 29(5) 138-43                       - see certolizumab 33(4) 129-131                complement inhibitors
Champix                                           Circadin                                        - eculizumab - paroxysmal nocturnal
- see varenicline 33(4) 120-3; 31(5) 115-8;       - see melatonin 33(2) 52-9                          haemoglobinuria - Soliris (New drug)
    31(3) 60-2; 31(1) 24-7                        citalopram                                          32(4) 112-5
chelating agents                                  - serotonin syndrome (medicinal mishap)         complementary medicines
- deferasirox - iron overload - Exjade (New          29(3) 71                                     - 1907 Royal Commission on Secret Drugs,
    drug) 29(4) 112-5                             climate change                                      Cures and Foods 30(4) 91
chemotherapy, cancer - see antineoplastics        - and infectious diseases (editorial) 32(3)     - - letter 30(6) 140-1
chest X-rays                                         58-9                                         - AUST R and AUST L numbers -
- testing for tuberculosis 33(1) 12-18            clindamycin                                         Medicines Safety Update 33(3) 80-3
- thoracic computed tomography 32(4)              - hepatotoxicity (medicinal mishap) 32(5)       - drug interactions 33(6) 177-80
    105-7                                            140                                          - - dental notes 33(6) 181
children (see also infants; attention deficit     clinical pharmacology - see pharmacology        - efficacy of Ginkgo biloba in tinnitus
    hyperactivity disorder)                       clinical tests - see abnormal laboratory            (editorial) 29(5) 120
- antidepressants and suicide risk (editorials)      results; diagnostic tests                    - - letter 30(2) 32-4
                                                  clinical trials                                 - fish oil and omega-3 fatty acids -
- - letter 29(2) 32-5                             - appraising medical research 29(5) 122-4           Medicines Safety Update 33(2) 48-51
- clofarabine - paediatric acute lymphocytic      - development of new prescription drugs         - regulation of advertising (editorial) 31(6)
    leukaemia - Evoltra (New drug) 33(2)             29(6) 159-61                                     142-3
    52-9                                          - interpreting risks and ratios 31(1) 12-6      compliance - see patient compliance
- cough and cold remedies 32(5) 122-4             - pharmacotherapy for risk factors 30(2)        compression therapy
- management of attention deficit                    47-50                                        - venous diseases 33(6) 186-90
    hyperactivity disorder 31(5) 129-32           - risk factor pharmacotherapy (letter) 30(4)    computed tomography
- managing painful paediatric procedures             88-90                                        - magnetic resonance imaging in
    29(4) 94-6                                    - surrogate outcome markers 32(2) 47-50             neuroradiology 31(1) 18-20
- - dental notes 29(4) 108                        clofarabine                                     - thoracic 32(4) 105-7
- - letters 29(6) 149-50                          - paediatric acute lymphocytic leukaemia -      computerised prescribing systems - see
- motion sickness prevention 32(3) 61-3              Evoltra (New drug) 33(2) 52-9                    electronic prescribing
- otitis media management 32(6) 155-9             clopidogrel                                     confidence intervals
- overdoses of over-the-counter drugs in          - antiplatelet therapy after coronary stents    - interpreting risks and ratios 31(1) 12-6
    infantile colic 29(3) 83                         30(4) 92-6                                   congenital abnormalities - see birth defects
- over-the-counter medications                    - response variability (editorial) 33(3) 62-3   congestive heart failure - see heart failure,
- - overdoses of anticholinergic drugs in         CMI - see Consumer Medicine                         congestive
    infantile colic 29(3) 83                         Information                                  Conn's syndrome
- paediatric analgesia 31(3) 63-5                 Co-Diovan                                       - abnormal laboratory results 30(6) 147-9
- - letters 31(6) 143-5                           - see valsartan with hydrochlorothiazide        constipation
- rotavirus vaccine - Rotarix (New drug)             32(1) 22-7                                   - management in adults 33(4) 116-9
    29(4) 112-5                                   cocaine                                         - methylnaltrexone bromide -
- rotavirus vaccine - RotaTeq (New drug)          - adverse effects 29(4) 109-11                      opioid-induced constipation - Relistor
    29(4) 112-5                                   codeine                                             (New drug) 32(1) 22-7
- withdrawal of antiepileptic drugs from          - combination analgesics in adults 33(4)        consumer - see consumers; patient
    seizure-free children 29(1) 18-21                113-5                                        consumer information (see also Consumer
chlamydia                                         - paediatric analgesia 31(3) 63-5                   Medicine Information)
- abnormal laboratory results 30(1) 8-13          cognition                                       - overseas travel and medicines 29(3) 80-2
chlorpromazine                                    - neurocognitive effects of chemotherapy        - pharmacotherapy for risk factors 30(2)
- in pregnancy and breastfeeding 30(6)               31(1) 22-4                                       47-50
    162-3                                                                                         - publishing of drug evaluations (editorial)
                                                                                                      29(5) 120
                                                                                                  - - letter 30(2) 32-4




                                                                       -7-
- starter packs and drug samples 30(1) 14-6      cortisol                                           - pharmacology of new oral anticoagulants
Consumer Medicine Information                    - abnormal laboratory results 30(6) 147-9              33(2) 38-41
- inadequate drug information sheets (letter)    cost of drugs                                      - prevention of postoperative venous
    31(6) 143-5                                  - drug price reforms (editorial) 30(6) 138-40          thrombosis - Pradaxa (New drug) 32(2)
- letter 31(2) 32                                - funding of influenza vaccination for                 51-5
- utilisation 30(5) 122-4                            healthy adults 30(2) 35-7                      dalteparin
consumers (see also patient's perspective,       - - letter 30(5) 116                               - heparins in venous thromboembolism
    consumer information)                        - prescription drug pricing 32(1) 6-8                  prophylaxis 32(4) 108-12
- direct drug advertising                        - - letter 32(3) 60                                danaparoid
- - in New Zealand (editorial) 29(2) 30-2        - prescription drug subsidies in Australia and     - heparins in venous thromboembolism
Continence Foundation of Australia                   New Zealand (editorial) 33(1) 2-4                  prophylaxis 32(4) 108-12
- patient support organisation 29(1) 24          - - letters 33(3) 64-7                             daptomycin
contraceptives                                   - top 10 drugs 33(6) 181; 32(6) 159; 31(6)         - skin infections, Staphylococcus aureus
- contraceptive failure and etonogestrel             164; 30(6) 142; 29(6) 167; 29(1) 5                 bacteraemia - Cubicin (New drug) 32(2)
    (Implanon)/carbamazepine interactions -      - US Medicare program (editorial) 32(4)                51-5
    Medicines Safety Update 33(6) 182-5              90-1                                           darbepoetin alfa
- dienogest/ethinyloestradiol - Valette (New     cost-effectiveness of drugs                        - management of anaemia in chronic kidney
    drug) 30(2) 50-5                             - expensive drugs and the Pharmaceutical               disease 32(5) 129-131
- overseas travel and medicines 29(3) 80-2           Benefits Scheme (editorial) 29(6) 146-8        darifenacin hydrobromide
- thromboembolism                                - - letter 30(3) 59-63                             - overactive bladder - Enablex (New drug)
- - prophylaxis and flying 32(6) 148-50          COX inhibitors                                         29(5) 138-43
- - - letters 33(2) 32-3; 33(2) 32-3; 33(2)      - etoricoxib - analgesia, gout, osteoarthritis -   darunavir
    32-3                                             Arcoxia (New drug) 32(5) 142-5                 - HIV infection - Prezista (New drug) 30(3)
contrast media                                   - lumiracoxib - Prexige (New drug) 29(1)               79-82
- disodium gadoxetate - liver imaging -              25-7                                           dasatinib
    Primovist (New drug) 29(3) 84-7              cramp                                              - chronic myeloid and acute lymphoblastic
- 'iodine allergy' 32(5) 125-8                   - magnesium (letter) 30(6) 140-1                       leukaemia - Sprycel (New drug) 30(2)
- - letter 33(3) 64-7                            creatinine clearance                                   50-5
- perflutren - ultrasound - Definity (New        - drug dosage adjustment in kidney disease         decision-support software - see electronic
    drug) 30(4) 107-11                               30(1) 17-20                                        prescribing
- safe use 33(1) 19-22                           - - letter 30(2) 32-4                              deep venous thrombosis - see
- - letter 33(3) 64-7                            Crestor                                                thromboembolism
COPD - see pulmonary disease, chronic            - see rosuvastatin 29(6) 167-71                    deferasirox
    obstructive                                  CT - see computed tomography                       - iron overload - Exjade (New drug) 29(4)
Corolan                                          Cubicin                                                112-5
- see ivabradine 30(2) 50-5                      - see daptomycin 32(2) 51-5                        Definity
coronary disease (see also angina;               Cushing's syndrome                                 - see perflutren 30(4) 107-11
    myocardial infarction)                       - abnormal laboratory results 30(6) 147-9          degarelix
- antiplatelet therapy after coronary stents     - mifepristone 32(6) 152-4                         - Firmagon - prostate cancer (New drug)
    30(4) 92-6                                   cyclo-oxygenase inhibitors - see COX                   33(6) 193-8
- clopidogrel response variability (editorial)       inhibitors                                     dementia - see Alzheimer's disease and
    33(3) 62-3                                   cyclosporin                                            dementia
- management of hypercholesterolaemia            - pharmacology of immunosuppressants               denosumab
    31(5) 119-22                                     29(4) 99-101                                   - Prolia - osteoporosis (New drug) 33(6)
coronary intervention, percutaneous              Cymbalta                                               193-8
- antiplatelet therapy after coronary stents     - see duloxetine 31(3) 79-83                       dental hygiene
    30(4) 92-6                                   cystic fibrosis                                    - for adults 32(3) 72-5
corticosteroids                                  - management of bronchiectasis 31(3) 77-9          - mouthwashes 32(6) 162-4
- in asthma 29(3) 63-6                           - - letter 31(5) 115-8                             dental implications - see dental notes
- in bronchiectasis 31(3) 77-9                   cytochrome P450                                    dental notes
- - letter 31(5) 115-8                           - warfarin pharmacogenetic testing 32(3)           - antibiotic resistance - multiresistant
- in chronic obstructive pulmonary disease           76-80                                              organisms 33(3) 71
    30(3) 64-7                                   - - letter 32(5) 119-121                           - - letters 33(6) 167-170; 33(5) 137
- - letter - alpha-1-antitrypsin deficiency      cytotoxic drugs - see antineoplastics              - bioequivalence of generic drugs 30(2) 43
    30(6) 140-1                                                                                     - bisphosphonates and osteonecrosis of the
- management of patients taking                  D                                                      jaws (letter) 33(6) 167-170
    immunosuppressants 32(3) 68-71                                                                  - combination analgesics in adults 33(4) 107
- osteoporosis and fractures 31(2) 45-9                                                             - drug interactions with complementary
                                                 dabigatran etexilate
- pharmacology of immunosuppressants                                                                    medicines 33(6) 181
                                                 - new oral anticoagulants in hip and knee
    29(4) 102-8                                                                                     - drug promotion and dentistry 30(6) 153
                                                     arthroplasty 33(2) 42-7
                                                                                                    - emergency drugs in dentistry 30(6) 146
                                                 - - letter 33(6) 167-170
                                                                                                    - herpes simplex infections 30(1) 13
                                                                                                    - infective endocarditis prophylaxis 31(6)
                                                                                                        153




                                                                       -8-
- influenza vaccination for healthy adults       dextropropoxyphene                                digoxin
    30(2) 37                                     - combination analgesics in adults 33(4)          - brands and dosages 29(6) 153
- management of hepatitis C 29(2) 52                 113-5                                         - - letter 30(2) 32-4
- - letter 30(3) 59-63                           diabetes                                          - therapeutic range (letter) 31(5) 115-8
- management of patients taking                  - blood glucose control (editorial) 32(2) 30-1    Diovan
    immunosuppressants 32(3) 75                  - blood glucose self-monitoring in type 2         - see valsartan 32(1) 22-7
- managing acute pain in opioid dependence           diabetes 33(5) 138-40                         dipeptidyl peptidase 4 inhibitors (see also
    31(5) 133-5                                  - clinical applications of incretins 31(4)            incretins)
- managing painful paediatric procedures             104-8                                         - clinical applications of incretins 31(4)
    29(4) 108                                    - drugs for gestational diabetes 33(5) 141-4          104-8
- myasthenia gravis 30(6) 160                    - exenatide - type 2 diabetes - Byetta (New       - pharmacology of incretins 31(4) 102-4
- neuropathic pain, drug treatment 29(3) 82          drug) 30(6) 163-7                             - sitagliptin - type 2 diabetes - Januvia (New
- psoriasis and periodontal disease 32(1) 18     - exercise 30(5) 130-3                                drug) 31(2) 49-55
- vitamin D deficiency in adults 33(4) 107       - - letter 31(1) 3-4                              - - letter 31(3) 60-2
- warfarin pharmacogenetic testing 32(3) 80      - foot infections 30(1) 21-4                      - vildagliptin - type 2 diabetes - Galvus
- xerostomia 29(4) 108                           - foot ulcers                                         (New drug) 33(3) 89-95
dental pain                                      - - prevention 31(4) 94-6                         Diphereline
- management 30(3) 77-9                          - insulin glulisine - Apidra SoloStar (New        - see triptorelin embonate 32(1) 22-7
- managing acute pain in opioid dependence           drug) 30(5) 133-5                             discharge medication
    31(5) 133-5                                  - insulin prescribing in small quantities         - information and prescriptions (editorial)
dental plaque                                        (PBAC question) 33(5) 144                         29(3) 58-9
- dental hygiene for adults 32(3) 72-5           - metformin in pregnancy and lactation            - - letters 29(5) 121
dentistry                                            30(3) 68-9                                    disease outbreaks
- bisphosphonates                                - overseas travel and insulin 29(3) 80-2          - antiviral drugs and influenza prophylaxis
- - and osteonecrosis of the jaws 30(4) 96-7     - pharmacology of incretins 31(4) 102-4               30(2) 30-1
- drugs and gingival bleeding 29(6) 154-5        - sitagliptin - type 2 diabetes - Januvia (New    disodium gadoxetate
- echocardiography and endocarditis (letter)         drug) 31(2) 49-55                             - liver imaging - Primovist (New drug) 29(3)
    30(1) 3-4                                    - - letter 31(3) 60-2                                 84-7
- mouthwashes 32(6) 162-4                        - thiazolidinedione adverse effects (editorial)   docetaxel
- and psychotropic drugs 30(4) 98-101                31(3) 58-9                                    - breast cancer (PBAC question) 30(1) 24-5
- Therapeutic Guidelines - Oral and Dental       - vildagliptin - type 2 diabetes - Galvus         doctor's bag
    (book review) 30(4) 106                          (New drug) 33(3) 89-95                        - see emergency supplies 30(6) 143-6
depression (see also antidepressant drugs)       diagnostic tests (see also abnormal               domiciliary services
- agomelatine - major depression - Valdoxan          laboratory results)                           - chronic obstructive pulmonary disease
    (New drug) 33(5) 160-3                       - diagnostic imaging                                  30(3) 64-7
- antidepressants and suicide risk in children   - - echocardiography 29(5) 134-8                  donepezil
    (editorials)                                 - - - letter 30(1) 3-4                            - Alzheimer's disease (editorial)
- - letter 29(2) 32-5                            - - magnetic resonance imaging in                 - - letter 29(3) 59-62
- antidepressants in pregnancy and                   neuroradiology 31(1) 18-20                    dopamine agonists
    breastfeeding 30(5) 125-7                    - - positron emission tomography 31(5)            - cabergoline-induced valvulopathy
- - letter 31(2) 32                                  123-8                                             (medicinal mishap) 31(1) 21
- duloxetine - major depression - Cymbalta       - - thoracic computed tomography 32(4)            - in pituitary tumours and prolactinoma
    (New drug) 31(3) 79-83                           105-7                                             32(1) 19-21
- in medical illness 30(4) 86-8                  - influenza 32(3) 64-7                            - pramipexole - Parkinson's disease, restless
- patient support organisations - perinatal      - melanoma 33(5) 150-5                                legs syndrome - Sifrol (New drug) 31(3)
    depression 31(2) 39                          - pitfalls in interpretation 32(2) 43-6               79-83
dermatology                                      - - letter 32(5) 119-121                          - in restless legs syndrome 31(4) 90-3
- Therapeutic Guidelines (book review)           - recurrent deep venous thrombosis 30(2)          - - letter 31(6) 143-5
    32(5) 139                                        38-40                                         - rotigotine - Parkinson's disease - Neupro
desvenlafaxine                                   - tuberculosis 33(1) 12-18                            (New drug) 31(2) 49-55
- antidepressant - Pristiq (New drug) 32(1)      dienogest/ethinyloestradiol                       Doribax
    22-7                                         - contraceptive - Valette (New drug) 30(2)        - see doripenem 32(3) 82-6
- new drug approvals (PBAC question)                 50-5                                          doripenem
    32(3) 63                                     diet                                              - specified infections - Doribax (New drug)
dexamphetamine                                   - fish oil and omega-3 fatty acids -                  32(3) 82-6
- in attention deficit hyperactivity disorder        Medicines Safety Update 33(2) 48-51           Down's syndrome
    31(5) 129-32                                 - lifestyle management of hypertension            - biochemical tests in pregnancy 29(2) 48-52
dextromethorphan                                     31(6) 150-3                                   driving
- precipitating serotonin syndrome 29(3) 71      - management of hypercholesterolaemia             - drug therapy and drug abuse 31(2) 33-5
- - letter 29(6) 149-50                              31(5) 119-22                                  drug abuse
                                                 - management of obesity 29(2) 43-7                - drugs and road safety 31(2) 33-5
                                                                                                   - Drugs of abuse (book review) 29(1) 8




                                                                       -9-
- managing acute pain in opioid dependence       - transparency of information about new           drug labelling
    31(5) 133-5                                      drugs                                         - label confusion between Atropt and Azopt
- psychostimulant poisoning 29(4) 109-11         - - transparency rating 32(3) 80-1; 30(1)             (medicinal mishap) 32(5) 138
drug allergy                                         26-7                                          drug monitoring
- sulfonamide allergy and cross-reactivity       - - - letter 29(3) 59-62                          - therapeutic
    (letter) 32(2) 31                            drug information                                  - - abnormal laboratory results 31(2) 42-4
drug bulletins - see drug information            - Australian Prescriber                           - - - therapeutic range of digoxin (letter)
drug compounding                                 - - 30th anniversary and history                      31(5) 115-8
- in community pharmacy (editorial) 31(2)        - - - letter 29(2) 32-5                           drug prescribing - see drug therapy; drug
    30-1                                         - - adverse reactions information 33(1) 9             utilisation; electronic prescribing
- - letter 31(5) 115-8                           - Consumer Medicine Information 30(5)             drug promotion - see advertising
drug costs - see cost of drugs                       122-4                                         drug regulation
drug evaluation                                  - - letter 31(2) 32                               - advertising
- appraising medical research 29(5) 122-4        - declarations of conflict of interest (letter)   - - direct-to-consumer advertising in New
- development of new prescription drugs              29(4) 91-3                                        Zealand (editorial) 29(2) 30-2
    29(6) 159-61                                 - Goodman & Gilman's The                          - - efficacy of Ginkgo biloba in tinnitus
- freedom of publication (editorial) 29(5)           pharmacological basis of therapeutics             (letter) 30(2) 32-4
    120                                              (book review) 29(1) 25                        - - of complementary medicines (editorial)
- - letter 30(2) 32-4                            - hospital discharge medication (editorial)           31(6) 142-3
- interpreting risks and ratios in clinical          29(3) 58-9                                    - drug compounding in community
    trials 31(1) 12-6                            - - letters 29(5) 121                                 pharmacy (editorial) 31(2) 30-1
- prescription drug subsidies in Australia and   - inadequate consumer drug information            - - letter 31(5) 115-8
    New Zealand (editorial) 33(1) 2-4                sheets (letter) 31(6) 143-5                   - drug industry payments to health
- - letters 33(3) 64-7                           - Medicines Safety Update 33(1) 10-11                 professionals (editorial) 33(5) 136-7
- regulation of complementary medicines          - publishing of drug evaluations (editorial)      - drug promotion and health professionals
    (editorial) 31(6) 142-3                          29(5) 120                                         30(6) 150-3
- surrogate outcome markers in clinical trials   - - letter 30(2) 32-4                             - prescription drug subsidies in Australia and
    32(2) 47-50                                  - Therapeutic Advice and Information                  New Zealand (editorial) 33(1) 2-4
- transparency of information about new              Service (TAIS) 33(5) 147-9                    - - letters 33(3) 64-7
    drugs                                        - Therapeutic Guidelines                          - rifampicin and MRSA infections - Orphan
- - transparency rating 32(3) 80-1; 30(1)        - - book reviews                                      Drug Scheme (letter) 29(1) 3-5
    26-7                                         - - - Dermatology 32(5) 139                       - starter packs and drug samples 30(1) 14-6
- - - letter 29(3) 59-62                         - - - Endocrinology 32(6) 151                     - surrogate outcome markers in clinical trials
drug industry (see also advertising)             - - PDA review - Mini TG (personal digital            32(2) 47-50
- 1907 Royal Commission on Secret Drugs,             assistant version) 29(1) 21                   - Therapeutic Goods Administration
    Cures and Foods 30(4) 91                     - transparency of information about new               approval processes 29(6) 159-61
- advertising of complementary medicines             drugs                                         - transparency of information about new
    (editorial) 31(6) 142-3                      - - transparency rating 32(3) 80-1; 30(1)             drugs
- development of new prescription drugs              26-7                                          - - two-way transparency 32(3) 80-1; 30(1)
    29(6) 159-61                                 - - - letter 29(3) 59-62                              26-7
- direct-to-consumer advertising                 - transparency of the Therapeutic Goods           - - - letter 29(3) 59-62
- - in New Zealand (editorial) 29(2) 30-2            Administration (editorial) 31(5) 114-5        - transparency of the Therapeutic Goods
- drug marketing and the internet 32(1) 2-4      drug interactions                                     Administration (editorial) 31(5) 114-5
- drug promotion and health professionals        - complementary medicines 33(6) 177-80            drug samples
    30(6) 150-3                                  - - dental notes 33(6) 181                        - starter packs and adverse effects 30(1)
- - letters 31(3) 60-2                           - contraceptive failure and etonogestrel              14-6
- Medicines Australia                                (Implanon)/carbamazepine interactions -       drug solutions
- - code of conduct breaches 33(6) 176;              Medicines Safety Update 33(6) 182-5           - compatibilities of parenteral drug solutions
    32(6) 160-1; 31(6) 162-3; 30(6) 153-5;       - depression in medical illness 30(4) 86-8            31(4) 98-101
    29(6) 164-5; 29(1) 16-7                      - meals and medicines 29(2) 40-2                  - - letter 31(6) 143-5
- - - letter 33(4) 101-2                         - polypharmacy (editorial) 31(1) 2-3              drug therapy (items relating to drugs
- - - vardenafil 30(6) 154                       - psychotropic drugs and dentistry 30(4)              generally)
- patent evergreening (editorial) 29(6) 148-9        98-101                                        - Aboriginal patients
- patent expiry and new drug approvals           - serotonin syndrome with                         - - letters 29(6) 149-50; 29(3) 59-62
    (PBAC question) 32(3) 63                         dextromethorphan and citalopram 29(3)         - Aboriginal people
- payment to health professionals (editorial)        71                                            - - subsidised medicines 32(5) 121; 31(4) 89
    33(5) 136-7                                  - statins, macrolides and rhabdomyolysis -        - advice for overseas travellers 29(3) 80-2
- publishing of drug evaluations (editorial)         Medicines Safety Update 33(5) 156-9           - bioequivalence of generic drugs 30(2) 41-3
    29(5) 120                                    - warfarin                                        - - letter 30(4) 88-90
- - letter 30(2) 32-4                            - - and fenofibrate 29(6) 166                     - collaboration between doctors and
- quality use of medicines (editorials) 33(4)    - - - letter 30(2) 32-4                               pharmacists 33(6) 191-3
    98-9; 33(4) 99-100                                                                             - competency for non-medical prescribers
- starter packs and adverse effects 30(1)                                                              (editorial) 30(3) 58-9
    14-6




                                                                       -10-
- Consumer Medicine Information 30(5)             echocardiography                                - - letters 31(1) 3-4; 30(4) 88-90
    122-4                                         - diagnostic tests 29(5) 134-8                  - Pharmaceutical Benefits Scheme drug
- - letter 31(2) 32                               - - letter 30(1) 3-4                                price reforms 30(6) 138-40
- drug dosage adjustment in kidney disease        - perflutren - contrast medium - Definity       - polypharmacy 31(1) 2-3
    30(1) 17-20                                       (New drug) 30(4) 107-11                     - prescription drug subsidies in Australia and
- - letter 30(2) 32-4                             ecstasy                                             New Zealand 33(1) 2-4
- drug industry and quality use of medicines      - adverse effects 29(4) 109-11                  - - letters 33(3) 64-7
    (editorials) 33(4) 98-9; 33(4) 99-100         eculizumab                                      - salmeterol - safety concerns 29(5) 118-9
- drugs and road safety 31(2) 33-5                - paroxysmal nocturnal haemoglobinuria -        - selective serotonin reuptake inhibitors and
- evidence-based medicine (editorial) 30(5)           Soliris (New drug) 32(4) 112-5                  suicide risk in children
    114-5                                         editorials                                      - - letter 29(2) 32-5
- expensive drugs and the Pharmaceutical          - advertising of complementary medicines        - thiazolidinedione adverse effects in
    Benefits Scheme (editorial) 29(6) 146-8           31(6) 142-3                                     diabetes 31(3) 58-9
- - letter 30(3) 59-63                            - antidepressants                               - transparency of the Therapeutic Goods
- hospital discharge - medication                 - - suicide risk in children                        Administration (editorial) 31(5) 114-5
    information and prescriptions (editorial)     - - - letter 29(2) 32-5                         - undertreatment of cardiovascular diseases
    29(3) 58-9                                    - antiviral drugs and influenza prophylaxis         in rural populations 31(4) 86-7
- - letters 29(5) 121                                 30(2) 30-1                                  - US Medicare program and cost of drugs
- meals and medicines 29(2) 40-2                  - bioequivalence of biosimilars 32(6) 146-7         32(4) 90-1
- non-medical prescribing in Australia            - - letter 33(2) 32-3                           efalizumab
    (editorial) 33(6) 166-7                       - chemotherapy and cancer survival rates        - in psoriasis 32(1) 14-8
- nurse prescribing                                   29(1) 2-3                                   - - update: withdrawal of efalizumab 32(2)
- - editorial 30(1) 2-3                           - climate change and infectious diseases            50
- - letters 31(1) 3-4; 30(4) 88-90                    32(3) 58-9                                  Effient
- pharmacotherapy for risk factors 30(2)          - clopidogrel response variability 33(3) 62-3   - see prasugrel 33(1) 22-7
    47-50                                         - competency for non-medical prescribers        eflornithine hydrochloride
- polypharmacy (editorial) 31(1) 2-3                  30(3) 58-9                                  - facial hair reduction - Vaniqa (New drug)
- prescribing in liver diseases 32(2) 32-5        - depression in medical illness 30(4) 86-8          29(3) 84-7
- - letters 32(5) 119-121                         - direct-to-consumer advertising in New         Elaprase
- risk factor pharmacotherapy (letter) 30(4)          Zealand (editorial) 29(2) 30-2              - see idursulfase 31(4) 108-11
    88-90                                         - donepezil in Alzheimer's disease              elderly - see aged
- starter packs and adverse effects 30(1)         - - letter 29(3) 59-62                          electrocardiography
    14-6                                          - drug compounding in community                 - Pocket guide to ECGs (book review) 29(4)
- US Medicare program (editorial) 32(4)               pharmacy 31(2) 30-1                             93
    90-1                                          - - letter 31(5) 115-8                          eletriptan
drug utilisation                                  - drug industry and quality use of medicines    - Relpax - migraine (New drug) 33(6) 193-8
- extended prescribing rights in the UK               33(4) 98-9; 33(4) 99-100                    Emend IV
    (editorial) 32(5) 118-9                       - drug industry payments to health              - see fosaprepitant 31(4) 108-11
- statistics - top 10 drugs 33(6) 181; 32(6)          professionals 33(5) 136-7                   Emerflu
    159; 31(6) 164; 30(6) 142; 29(6) 167;         - drug patent evergreening 29(6) 148-9          - see influenza H5N1 vaccines 32(6)
    29(1) 5                                       - evidence-based medicine - turning                 165-171
- undertreatment of cardiovascular diseases           knowledge into action 30(5) 114-5           emergency contraception
    in rural populations (editorial) 31(4) 86-7   - expensive drugs and the Pharmaceutical        - mifepristone 32(6) 152-4
duloxetine                                            Benefits Scheme 29(6) 146-8                 emergency supplies
- Cymbalta - major depression (New drug)          - - letter 30(3) 59-63                          - emergency drugs - doctor's bag supplies
    31(3) 79-83                                   - extended prescribing rights in the UK             30(6) 143-6
Duratocin                                             32(5) 118-9                                 - emergency drugs in dentistry 30(6) 146
- see carbetocin 30(4) 107-11                     - freedom of publication of drug evaluations    Enablex
dutasteride                                           29(5) 120                                   - see darifenacin hydrobromide 29(5)
- benign prostatic hyperplasia - Avodart          - - letters 30(2) 32-4                              138-43
    (New drug) 32(4) 112-5                        - gentamicin toxicity and monitoring 33(5)      endocarditis
DVT - see thromboembolism                             134-5                                       - antibiotic prophylaxis
dyspepsia                                         - glucose control in diabetes 32(2) 30-1        - - dental notes 31(6) 153
- proton pump inhibitors - long-term              - hospital discharge - medication               endocrinology
    management 31(1) 5-7                              information and prescriptions 29(3) 58-9    - Therapeutic Guidelines - book review
                                                  - - letters 29(5) 121                               32(6) 151
E                                                 - influenza H1N1 vaccine 33(2) 30-1             endothelin receptor antagonists
                                                  - - letters 33(3) 64-7                          - ambrisentan - pulmonary arterial
                                                  - non-medical prescribing in Australia 33(6)        hypertension - Volibris (New drug) 33(1)
ear
                                                      166-7                                           22-7
- ear drops and ototoxicity 31(2) 40-1
                                                  - NSAIDs and cardiovascular disease in          - sitaxentan - pulmonary hypertension -
- otitis media management in children 32(6)
                                                      rheumatology 29(4) 90-1                         Thelin (New drug) 31(3) 79-83
   155-9
                                                  - nurse prescribing 30(1) 2-3




                                                                      -11-
enfuvirtide                                     etanercept                                     eye (see also specific diseases)
- pharmacology of HIV fusion inhibitors         - in psoriasis 32(1) 14-8                      - eye drops, correct use 31(1) 16-7
    31(3) 66-9                                  - tumour necrosis factor blockers in           - - letter 31(4) 88-9
England - see United Kingdom                        rheumatology 29(3) 67-70
enoxaparin                                      ethics                                         F
- heparins in venous thromboembolism            - drug promotion and health professionals
    prophylaxis 32(4) 108-12                        30(6) 150-3
                                                                                               factor VIII
entecavir                                       - - letters 31(3) 60-2
                                                                                               - inhibitor bypassing fraction - FEIBA-NF -
- chronic hepatitis B - Baraclude (New drug)    - Pharmacy law and ethics (book review)
                                                                                                   haemophilia (New drug) 30(2) 50-5
    29(5) 138-43                                    33(5) 155
                                                                                               Faslodex
epidemics                                       ethinyloestradiol
                                                                                               - see fulvestrant 30(4) 107-11
- see disease outbreaks 30(2) 30-1              - dienogest combination - contraceptive -
                                                                                               FEIBA-NF
epidermal necrolysis, toxic                         Valette (New drug) 30(2) 50-5
                                                                                               - see factor VIII inhibitor bypassing fraction
- lamotrigine and serious skin reactions -      etonogestrel
                                                                                                   30(2) 50-5
    Medicines Safety Update 33(6) 182-5         - contraceptive failure and etonogestrel
                                                                                               fenofibrate
epilepsy (see also anticonvulsants)                 (Implanon)/carbamazepine interactions -
                                                                                               - warfarin interactions 29(6) 166
- anticonvulsants in pregnancy and                  Medicines Safety Update 33(6) 182-5
                                                                                               - - letter 30(2) 32-4
    breastfeeding 31(3) 70-2                    etoricoxib
                                                                                               Firazyr
- lacosamide - partial-onset epileptic          - analgesia, gout, osteoarthritis - Arcoxia
                                                                                               - see icatibant 33(6) 193-8
    seizures - Vimpat (New drug) 33(1) 22-7         (New drug) 32(5) 142-5
                                                                                               Firmagon
- withdrawal of drugs from seizure-free         etravirine
                                                                                               - see degarelix 33(6) 193-8
    children 29(1) 18-21                        - HIV infection - Intelence (New drug) 32(2)
                                                                                               fish
EpiPen                                              51-5
                                                                                               - management of venomous puncture
- see adrenaline 29(2) 52-3                     evergreening
                                                                                                   injuries 30(5) 117-21
eplerenone                                      - drug patents (editorial) 29(6) 148-9
                                                                                               - - letter 31(2) 32
- heart failure after myocardial infarction -   everolimus
                                                                                               fish oil
    Inspra (New drug)                           - pharmacology of immunosuppressants
                                                                                               - Medicines Safety Update 33(2) 48-51
- - letter 29(2) 32-5                               29(4) 99-101
                                                                                               - NSAIDs in rheumatology (editorial) 29(4)
epoetin alfa                                    evidence-based medicine
                                                                                                   90-1
- management of anaemia in chronic kidney       - appraising medical research 29(5) 122-4
                                                                                               flow cytometry
    disease 32(5) 129-131                       - pharmacotherapy for risk factors 30(2)
                                                                                               - abnormal laboratory results 30(5) 128-9
epoetin beta                                        47-50
                                                                                               fluorodeoxyglucose
- anaemia - NeoRecormon (New drug) 29(4)        - - letter 30(4) 88-90
                                                                                               - positron emission tomography 31(5) 123-8
    112-5                                       - turning knowledge into action (editorial)
                                                                                               fluoroquinolones
- management of anaemia in chronic kidney           30(5) 114-5
                                                                                               - ear drops and ototoxicity 31(2) 40-1
    disease 32(5) 129-131                       Evoltra
                                                                                               fluoxetine
- methoxy polyethylene glycol-epoetin beta      - see clofarabine 33(2) 52-9
                                                                                               - selective serotonin reuptake inhibitors and
    - anaemia in chronic kidney disease -       exenatide
                                                                                                   suicide risk in children (editorial)
    Mircera (New drug) 32(6) 165-171            - clinical applications of incretins 31(4)
                                                                                               - - letter 29(2) 32-5
Eraxis                                              104-8
                                                                                               fluticasone
- see anidulafungin 32(6) 165-171               - pancreatitis - Medicines Safety Update
                                                                                               - corticosteroid therapy in asthma 29(3) 63-6
ergocalciferol                                      33(3) 80-3
                                                                                               folic acid
- vitamin D deficiency in adults 33(4) 103-6    - type 2 diabetes - Byetta (New drug) 30(6)
                                                                                               - anticonvulsants in pregnancy and
erlotinib                                           163-7
                                                                                                   breastfeeding 31(3) 70-2
- non-small cell lung cancer - Tarceva (New     exercise
                                                                                               fondaparinux
    drug) 29(2) 53-5                            - diabetes 30(5) 130-3
                                                                                               - heparins in venous thromboembolism
erythrocyte sedimentation rate                  - - letter 31(1) 3-4
                                                                                                   prophylaxis 32(4) 108-12
- C-reactive protein - abnormal laboratory      exercise testing
                                                                                               food
    results 30(3) 74-6                          - diabetes 30(5) 130-3
                                                                                               - isomaltulose - sugar substitute - warning in
erythropoietin                                  - - letter 31(1) 3-4
                                                                                                   fructose metabolism disorders (letter)
- epoetin beta - anaemia - NeoRecormon          Exforge
                                                                                                   31(1) 3-4
    (New drug) 29(4) 112-5                      - see amlodipine with valsartan 32(1) 22-7
                                                                                               - meals and medicines 29(2) 40-2
- management of anaemia in chronic kidney       Exjade
                                                                                               - seafood and 'iodine allergy' 32(5) 125-8
    disease 32(5) 129-131                       - see deferasirox 29(4) 112-5
                                                                                               - - letter 33(3) 64-7
- methoxy polyethylene glycol-epoetin beta      experimental pharmacology - see
                                                                                               foot infections
    - anaemia in chronic kidney disease -           pharmacology
                                                                                               - in diabetes 30(1) 21-4
    Mircera (New drug) 32(6) 165-171            extemporaneous dispensing
                                                                                               foot ulcers
esterase inhibitors                             - drug compounding in community
                                                                                               - prevention 31(4) 94-6
- human C1 esterase inhibitor - hereditary          pharmacy (editorial) 31(2) 30-1
                                                                                               fosaprepitant
    angioedema - Berinert (New drug) 33(3)      - - letter 31(5) 115-8
                                                                                               - emetogenic cancer chemotherapy (New
    89-95
                                                                                                   drug) 31(4) 108-11




                                                                    -12-
Fosrenol                                          - Pharmaceutical Benefits Scheme drug          haemophilia
- see lanthanum carbonate 29(2) 53-5                  price reforms (editorial) 30(6) 138-40     - factor VIII inhibitor bypassing fraction -
fructose metabolism disorders                     gentamicin                                         FEIBA-NF (New drug) 30(2) 50-5
- warning about isomaltulose sugar                - toxicity and monitoring (editorial) 33(5)    hair growth reduction
   substitute (letter) 31(1) 3-4                      134-5                                      - eflornithine hydrochloride - facial hair -
fulvestrant                                       geriatric - see aged                               Vaniqa (New drug) 29(3) 84-7
- Faslodex - breast cancer (New drug) 30(4)       gingival enlargement                           hay fever - see rhinitis, allergic
   107-11                                         - drug-induced 29(6) 154-5                     HDL cholesterol - see cholesterol
fungal infections                                 Ginkgo biloba                                  headache (see also migraine)
- posaconazole - Noxafil (New drug) 29(3)         - efficacy in tinnitus (editorial) 29(5) 120   - and analgesic overuse
   84-7                                           - - letter 30(2) 32-4                          - - letter 29(3) 59-62
                                                  glaucoma                                       hearing disorders
G                                                 - label confusion between Atropt and Azopt     - ear drops and ototoxicity 31(2) 40-1
                                                      (medicinal mishap) 32(5) 138               heart failure, congestive
                                                  glitazones - see thiazolidinediones            - management in chronic kidney disease
gadolinium
                                                  global warming - see climate change                31(6) 154-8
- safe use of radiographic contrast media
                                                  glomerular filtration rate                     - nebivolol - Nebilet (New drug) 33(2) 52-9
    33(1) 19-22
                                                  - drug dosage adjustment in kidney disease     - - correction 33(4) 131
gadoxetate disodium
                                                      30(1) 17-20                                - - letter 33(4) 101-2
- Primovist - liver imaging (New drug) 29(3)
                                                  - - letter 30(2) 32-4                          - valsartan - Diovan (New drug) 32(1) 22-7
    84-7
                                                  glucagon-like peptide-1 agonists (see also     heart valve diseases
galsulfase
                                                      incretins)                                 - cabergoline-induced valvulopathy
- mucopolysaccharidosis VI - Naglazyme
                                                  - clinical applications of incretins 31(4)         (medicinal mishap) 31(1) 21
    (New drug) 31(5) 136-9
                                                      104-8                                      Helicobacter pylori
Galvus
                                                  - pharmacology of incretins 31(4) 102-4        - proton pump inhibitors - long-term
- see vildagliptin 33(3) 89-95
                                                  glucocorticoid receptor antagonists                management 31(1) 5-7
Gardasil
                                                  - mifepristone 32(6) 152-4                     heparins
- see human papillomavirus vaccine 29(5)
                                                  glucose                                        - venous thromboembolism prophylaxis
    138-43
                                                  - blood glucose self-monitoring in type 2          32(4) 108-12
gastro-oesophageal reflux disease
                                                      diabetes 33(5) 138-40                      - - and flying 32(6) 148-50
- proton pump inhibitors
                                                  - control in diabetes (editorial) 32(2) 30-1   - - - letters 33(2) 32-3; 33(2) 32-3; 33(2)
- - long-term management 31(1) 5-7
                                                  glycogen storage diseases                          32-3
gastroenteritis
                                                  - alglucosidase alfa - Pompe disease -         - - letter 33(6) 167-170
- rotavirus vaccine - Rotarix (New drug)
                                                      Myozyme (New drug) 31(3) 79-83             hepatitis B
    29(4) 112-5
                                                  golimumab                                      - entecavir - Baraclude (New drug) 29(5)
- rotavirus vaccine - RotaTeq (New drug)
                                                  - rheumatoid arthritis, psoriatic arthritis,       138-43
    29(4) 112-5
                                                      ankylosing spondylitis - Simponi (New      - management 32(4) 99-104
gastroenterology
                                                      drug) 33(1) 22-7                           - telbivudine - Sebivo (New drug) 30(6)
- Therapeutic Guidelines - book reviews
                                                  gonorrhoea                                         163-7
    30(2) 46
                                                  - abnormal laboratory results 30(1) 8-13       hepatitis C
gastrointestinal haemorrhage
                                                  gout                                           - dental notes 29(2) 52
- paracetamol adverse effects (letter) 30(3)
                                                  - etoricoxib - Arcoxia (New drug) 32(5)        - - letter 30(3) 59-63
    59-63
                                                      142-5                                      - management 29(2) 36-9
gastrointestinal stromal tumour
                                                  Great Britain - see United Kingdom             - patient support organisation 29(2) 39
- sunitinib - Sutent (New drug) 29(6) 167-71
                                                  guidelines (see also therapeutic guidelines)   heroin dependence
Gaucher's disease type I
                                                  - turning knowledge into action (editorial)    - management of acute pain 31(5) 133-5
- miglustat - type 1 Gaucher disease -
                                                      30(5) 114-5                                herpes simplex
    Zavesca (New drug) 33(3) 89-95
                                                  gum disease - see periodontitis, gingival      - genital herpes
- - correction 33(4) 131
                                                  Gynazole                                       - - abnormal laboratory results 30(1) 8-13
general practice
                                                  - see butoconazole nitrate 29(5) 138-43        - - dental notes 30(1) 13
- collaboration between doctors and
                                                                                                 herpes zoster
    pharmacists 33(6) 191-3
                                                  H                                              - vaccine, Zostavax (New drug) 31(1) 24-7
- drugs for the doctor's bag 30(6) 143-6
                                                                                                 - varicella vaccination (letter) 30(5) 116
- point-of-care testing 33(1) 6-9
                                                                                                 hirsutism
- - letter 33(6) 167-170                          haematology
                                                                                                 - eflornithine hydrochloride - facial hair -
generic drugs                                     - diagnostic immunology - abnormal
                                                                                                     Vaniqa (New drug) 29(3) 84-7
- bioequivalence                                     laboratory results 30(5) 128-9
                                                                                                 histamine H1 antagonists
- - and pharmacokinetics 30(2) 41-3               haematopoietic stem cell transplantation
                                                                                                 - motion sickness prevention in children
- - - letters 30(4) 88-90                         - adult leukaemia 29(3) 76-9
                                                                                                     32(3) 61-3
- biosimilars are not (bio)generics (editorial)   haemoglobinuria
                                                                                                 HIV/AIDS
    32(6) 146-7                                   - eculizumab - paroxysmal nocturnal
                                                                                                 - abnormal laboratory results 30(1) 8-13
- - letter 33(2) 32-3                                haemoglobinuria - Soliris (New drug)
                                                                                                 - darunavir - Prezista (New drug) 30(3)
- patent evergreening (editorial) 29(6) 148-9        32(4) 112-5
                                                                                                     79-82




                                                                      -13-
- etravirine - Intelence (New drug) 32(2)       hyperphosphataemia
    51-5                                        - lanthanum carbonate hydrate - chronic           I
- maraviroc - Celsentri (New drug) 31(6)            renal failure - Fosrenol (New drug) 29(2)
    165-7                                           53-5
                                                                                                  I f current inhibitors
- pharmacology of HIV fusion inhibitors         hypersensitivity - see allergy, penicillin
                                                                                                  - ivabradine - angina - Corolan (New drug)
    31(3) 66-9                                      allergy
                                                                                                      30(2) 50-5
- raltegravir - Isentress (New drug) 31(2)      hypertension (see also antihypertensives)
                                                                                                  ibandronic acid
    49-55                                       - beta blockers 30(1) 5-7
                                                                                                  - hypercalcaemia, bony metastases of breast
- tipranavir - Aptivus (New drug) 30(4)         - - letter 30(3) 59-63
                                                                                                      cancer - Bondronat (New drug) 31(3)
    107-11                                      - drug treatment of elevated blood pressure
                                                                                                      79-83
hormone replacement therapy                         33(4) 108-12
                                                                                                  ibuprofen
- management of menopausal symptoms             - lifestyle management 31(6) 150-3
                                                                                                  - paediatric analgesia 31(3) 63-5
    33(6) 171-5                                 - management in Aboriginal people 33(3)
                                                                                                  icatibant
hospitals                                           72-5
                                                                                                  - Firazyr - hereditary angioedema (New
- discharge medication - information and        - management in chronic kidney disease
                                                                                                      drug) 33(6) 193-8
    prescriptions (editorial) 29(3) 58-9            31(6) 154-8
                                                                                                  idursulfase
- - letters 29(5) 121                           - nebivolol - Nebilet (New drug) 33(2) 52-9
                                                                                                  - Hunter syndrome - Elaprase (New drug)
- prescription drug pricing (letter) 32(3) 60   - - correction 33(4) 131
                                                                                                      31(4) 108-11
human C1 esterase inhibitors                    - - letter 33(4) 101-2
                                                                                                  imaging - see diagnostic tests or specific
- Berinert - hereditary angioedema (New         - paracetamol and blood pressure (letter)
                                                                                                      method
    drug) 33(3) 89-95                               30(3) 59-63
                                                                                                  imatinib
- icatibant - hereditary angioedema - Firazyr   - pharmacology of renin inhibitors 32(5)
                                                                                                  - adult leukaemia 29(3) 76-9
    (New drug) 33(6) 193-8                          132-5
                                                                                                  immunisation - see vaccination
human chorionic gonadotrophin                   - renin inhibitors 32(5) 135-8
                                                                                                  immunity, cellular
- biochemical tests for abnormalities in        - - letter 33(3) 64-7
                                                                                                  - tests for cell-mediated immunity -
    pregnancy 29(2) 48-52                       hypertension, pulmonary - see pulmonary
                                                                                                      abnormal laboratory results 33(3) 84-7
human papillomavirus vaccine                        hypertension
                                                                                                  immunocytochemistry
- Cervarix (New drug) 30(5) 133-5               hypnotics
                                                                                                  - abnormal laboratory results 30(5) 128-9
- Gardasil (New drug) 29(5) 138-43              - adverse effects of zolpidem and zopiclone
                                                                                                  immunodeficiency
Hunter syndrome                                     in insomnia 31(6) 146-9
                                                                                                  - tests for cell-mediated immunity -
- idursulfase - Elaprase (New drug) 31(4)       hypogammaglobulinaemia
                                                                                                      abnormal laboratory results 33(3) 84-7
    108-11                                      - tests for cell-mediated immunity -
                                                                                                  immunoglobulins
hydrochlorothiazide                                 abnormal laboratory results 33(3) 84-7
                                                                                                  - intravenous - safety of plasma-derived
- with valsartan - Co-Diovan (New drug)         hypoglycaemia
                                                                                                      products 33(3) 76-9
    32(1) 22-7                                  - glucose control in diabetes (editorial) 32(2)
                                                                                                  immunophenotyping
hyoscine                                            30-1
                                                                                                  - abnormal laboratory results 30(5) 128-9
- motion sickness prevention in children        hypoglycaemic drugs
                                                                                                  immunosuppressants
    32(3) 61-3                                  - clinical applications of incretins 31(4)
                                                                                                  - experimental and clinical pharmacology
hyperactivity disorder in children                  104-8
                                                                                                      29(4) 99-101; 29(4) 102-8
- management 31(5) 129-32                       - drugs for gestational diabetes 33(5) 141-4
                                                                                                  - long-term management 32(3) 68-71
hyperaldosteronism                              - exenatide - type 2 diabetes - Byetta (New
                                                                                                  - - dental notes 32(3) 75
- abnormal laboratory results 30(6) 147-9           drug) 30(6) 163-7
                                                                                                  - in myasthenia gravis 30(6) 156-60
hypercalcaemia                                  - metformin in pregnancy and lactation
                                                                                                  Implanon
- ibandronic acid - tumour-induced                  30(3) 68-9
                                                                                                  - see etonogestrel 33(6) 182-5
    hypercalcaemia - Bondronat (New drug)       - pharmacology of incretins 31(4) 102-4
                                                                                                  impotence - see erectile dysfunction and
    31(3) 79-83                                 hypomagnesaemia
                                                                                                      impotence
hypercholesterolaemia                           - abnormal laboratory results 30(4) 102-5
                                                                                                  incretins (see also dipeptidyl peptidase 4
- management 31(5) 119-22                       - - letter 30(6) 140-1
                                                                                                      inhibitors, glucagon-like peptide-1
- rosuvastatin - Crestor (New drug) 29(6)       hyponatraemia
                                                                                                      agonists)
    167-71                                      - mirtazapine-induced hyponatraemia
                                                                                                  - in diabetes - clinical applications 31(4)
hyperlipidaemia (see also antilipidaemic            (medicinal mishap) 31(4) 97
                                                                                                      104-8
    drugs and hypercholesterolaemia)            - - letter 32(1) 5
                                                                                                  - in diabetes - pharmacology 31(4) 102-4
- management in chronic kidney disease          hypothyroidism
                                                                                                  - exenatide - type 2 diabetes - Byetta (New
    31(6) 154-8                                 - thyroid replacement therapy 31(6) 159-61
                                                                                                      drug) 30(6) 163-7
hypermagnesaemia                                - thyroxine administration and
                                                                                                  indacaterol
- abnormal laboratory results 30(4) 102-5           pharmacokinetics
                                                                                                  - Onbrez Breezhaler - chronic obstructive
hyperparathyroidism                             - - shelf-life of thyroxine (letter)
                                                                                                      pulmonary disease (New drug) 33(5)
- paricalcitol - secondary                      - - - and refrigeration (letter) 29(2) 32-5
                                                                                                      160-3
    hyperparathyroidism - Zemplar (New          hypovolaemia
                                                                                                  infants (see also breastfeeding, newborn)
    drug) 31(4) 108-11                          - pentastarch - Voluven (New drug) 30(4)
                                                                                                  - cough and cold remedies 32(5) 122-4
                                                    107-11
                                                                                                  - nitric oxide - neonatal respiratory failure -
                                                                                                      INOmax (New drug) 31(1) 24-7




                                                                     -14-
- overdoses of over-the-counter drugs in         Inspra                                           ivabradine
    infantile colic 29(3) 83                     - see eplerenone 29(2) 32-5                      - angina - Corolan (New drug) 30(2) 50-5
- treatment of perinatal depression 31(2)        insulin
    36-9                                         - drugs for gestational diabetes 33(5) 141-4     J
infection                                        - prescribing in small quantities (PBAC
- antibiotic resistance - multiresistant             question) 33(5) 144
                                                                                                  Januvia
    organisms 33(3) 68-71                        insulin glulisine
                                                                                                  - see sitagliptin (New drug) 31(3) 60-2;
- climate change and infectious diseases         - diabetes - Apidra SoloStar (New drug)
                                                                                                      31(2) 49-55
    (editorial) 32(3) 58-9                           30(5) 133-5
                                                                                                  Japanese encephalitis vaccine
- C-reactive protein - abnormal laboratory       Intanza
                                                                                                  - Jespect (New drug) 32(3) 82-6
    results 30(3) 74-6                           - see influenza seasonal vaccine 32(6)
                                                                                                  jaw diseases
- management of dental and oral pain 30(3)           165-171
                                                                                                  - bisphosphonates and osteonecrosis 30(4)
    77-9                                         Intelence
                                                                                                      96-7
inflammation                                     - see etravirine 32(2) 51-5
                                                                                                  - - letter 33(6) 167-170
- C-reactive protein - abnormal laboratory       interactions - see drug interactions
                                                                                                  jellyfish
    results 30(3) 74-6                           interferon
                                                                                                  - management of stings 30(5) 117-21
- management of dental and oral pain 30(3)       - interferon gamma release assays -
                                                                                                  - - letter 31(2) 32
    77-9                                             tuberculosis diagnosis 33(1) 12-18
                                                                                                  Jespect
- monoclonal antibodies 29(5) 130-3              - peginterferon/ribavirin combination in
                                                                                                  - see Japanese encephalitis vaccine 32(3)
infliximab                                           hepatitis C 29(2) 36-9
                                                                                                      82-6
- in psoriasis 32(1) 14-8                        - pegylated interferon in hepatitis B 32(4)
- tumour necrosis factor blockers in                 99-104
    rheumatology 29(3) 67-70                     interleukin 12/23 receptor antagonists           K
influenza                                        - ustekinumab - psoriasis - Stelara (New
- antiviral drugs and influenza prophylaxis          drug) 33(2) 52-9                             kidney diseases
    (editorial) 30(2) 30-1                       interleukin-6 receptor antagonists               - drug dosage adjustment 30(1) 17-20
- H1N1 vaccine                                   - tocilizumab - rheumatoid arthritis -           - - letter 30(2) 32-4
- - editorial 33(2) 30-1                             Actemra (New drug) 32(4) 112-5               - drug treatment of renal cell cancer 29(6)
- - - letters 33(3) 64-7                         intermittent claudication                            151-3
- - letter 33(1) 5                               - cilostazol - Pletal (New drug) 32(3) 82-6      - lanthanum carbonate hydrate -
- - Panvax and Panvax Junior - Medicines         internet                                             hyperphosphataemia in chronic renal
    Safety Update 33(4) 120-3                    - Australian Prescriber website user surveys         failure - Fosrenol (New drug) 29(2) 53-5
- - Panvax H1N1 vaccine (New drug) 32(6)             30(1) 16                                     - management of anaemia in chronic kidney
    165-171                                      - drug marketing 32(1) 2-4                           disease 32(5) 129-131
- H5N1 vaccines - Pandemrix, Panvax and          interstitial nephritis                           - management of bone disease 33(2) 34-7
    Emerflu (New drugs) 32(6) 165-171            - with omeprazole (medicinal mishap) 30(3)       - managing cardiovascular disease risk in
- rapid diagnostic tests 32(3) 64-7                  67                                               chronic kidney disease 31(6) 154-8
- seasonal vaccine - Intanza (New drug)          intrauterine devices                             - methoxy polyethylene glycol-epoetin beta
    32(6) 165-171                                - uterine perforation and                            - anaemia in chronic kidney disease -
- vaccination                                        levonorgestrel-releasing intrauterine            Mircera (New drug) 32(6) 165-171
- - for healthy adults 30(2) 35-7                    system - Medicines Safety Update 33(5)       - renal cell cancer
- - - letter 30(5) 116                               156-9                                        - - drug treatment 29(6) 151-3
- - - PBAC question 30(3) 83                     Invega                                           - renal cell carcinoma - temsirolimus -
infusions, parenteral                            - see paliperidone 31(2) 49-55                       Torisel (New drug) 31(4) 108-11
- compatibilities of drug solutions 31(4)        iodine                                           - sorafenib - Nexavar - renal cell cancer
    98-101                                       - contrast media, seafood and 'iodine allergy'       (New drug) 29(6) 167-71
- - letter 31(6) 143-5                               32(5) 125-8                                  - sunitinib - Sutent - renal cell cancer (New
injections                                       - - letter 33(3) 64-7                                drug) 29(6) 167-71
- compatibilities of parenteral drug solutions   - safe use of radiographic contrast media        kidney failure
    31(4) 98-101                                     33(1) 19-22                                  - omeprazole and interstitial nephritis 30(3)
- - letter 31(6) 143-5                           iron deficiency                                      67
- managing painful paediatric procedures         - management of anaemia in chronic kidney        - paricalcitol - secondary
    29(4) 94-6                                       disease 32(5) 129-131                            hyperparathyroidism - Zemplar (New
- - letters 29(6) 149-50                         iron overload                                        drug) 31(4) 108-11
INOmax                                           - deferasirox - Exjade (New drug) 29(4)          - safe use of radiographic contrast media
- see nitric oxide 31(1) 24-7                        112-5                                            33(1) 19-22
insomnia                                         Isentress                                        - - letter 33(3) 64-7
- adverse effects of zolpidem and zopiclone      - see raltegravir 31(2) 49-55                    kidney function tests
    31(6) 146-9                                  isomaltulose                                     - drug dosage adjustment in kidney disease
- melatonin                                      - sugar substitute - warning in fructose             30(1) 17-20
- - Circadin (New drug) 33(2) 52-9                   metabolism disorders (letter) 31(1) 3-4      - - letter 30(2) 32-4




                                                                      -15-
kidney transplantation                         - nilotinib - chronic myeloid leukaemia -         - miglustat - type 1 Gaucher disease and
- anti-thymocyte globulin - Thymoglobuline         Tasigna (New drug) 31(2) 49-55                   Niemann-Pick disease type C - Zavesca
   (New drug) 31(5) 136-9                      - treatment of adult leukaemia 29(3) 76-9            (New drug) 33(3) 89-95
                                               levonorgestrel
L                                              - uterine perforation and                         M
                                                   levonorgestrel-releasing intrauterine
                                                   system - Medicines Safety Update 33(5)
laboratory results - see abnormal                                                                MabCampath
                                                   156-9
    laboratory results                                                                           - see alemtuzumab 29(6) 167-71
                                               LHRH - see luteinising hormone releasing
lacosamide                                                                                       macular degeneration
                                                   hormone
- partial-onset epileptic seizures - Vimpat                                                      - anecortave - Retaane (New drug) 29(2)
                                               Li - see lithium
    (New drug) 33(1) 22-7                                                                            53-5
                                               lifestyle-related disease
lactation - see breastfeeding                                                                    - ranibizumab - Lucentis (New drug) 30(3)
                                               - management of hypertension,
lamotrigine                                                                                          79-82
                                                   cardiovascular disease 31(6) 150-3
- in bipolar disorders 30(3) 70-3                                                                magnesium
                                               liraglutide
- and serious skin reactions - Medicines                                                         - abnormal laboratory results 30(4) 102-5
                                               - clinical applications of incretins 31(4)
    Safety Update 33(6) 182-5                                                                    - - letter 30(6) 140-1
                                                   104-8
lanthanum carbonate hydrate                                                                      magnetic resonance angiography
                                               lithium
- hyperphosphataemia in chronic renal                                                            - cerebrovascular imaging 31(1) 18-20
                                               - in bipolar disorders 31(3) 73-6; 30(3) 70-3
    failure - Fosrenol (New drug) 29(2) 53-5                                                     magnetic resonance imaging
                                               liver (see also hepatitis)
lapatinib                                                                                        - disodium gadoxetate - liver imaging -
                                               - cirrhosis - management of hepatitis B
- breast cancer - Tykerb (New drug) 30(5)                                                            Primovist (New drug) 29(3) 84-7
                                                   32(4) 99-104
    133-5                                                                                        malaria
                                               - clindamycin and hepatotoxicity (medicinal
laronidase                                                                                       - climate change and infectious diseases
                                                   mishap) 32(5) 140
- mucopolysaccharidosis I - Aldurazyme                                                               32(3) 58-9
                                               - disodium gadoxetate - Primovist - liver
    (New drug) 30(3) 79-82                                                                       manic disorder - see bipolar disorders
                                                   imaging (New drug) 29(3) 84-7
Law (see also legal issues)                                                                      maraviroc
                                               - drug metabolism in liver diseases 32(2)
laxatives                                                                                        - Celsentri - HIV infection (New drug) 31(6)
                                                   32-5
- management of constipation in adults 33(4)                                                         165-7
                                               - - letters 32(5) 119-121
    116-9                                                                                        Maroteaux-Lamy syndrome
                                               - liver function tests - hepatitis C 29(2) 36-9
- methylnaltrexone bromide -                                                                     - galsulfase - Naglazyme (New drug) 31(5)
                                               liver diseases
    opioid-induced constipation - Relistor                                                           136-9
                                               - drug prescribing 32(2) 32-5
    (New drug) 32(1) 22-7                                                                        Maxalt
                                               - - letters 32(5) 119-121
leg ulcers                                                                                       - see rizatriptan 33(2) 52-9
                                               Lucentis
- compression therapy 33(6) 186-90                                                               media, mass - see mass media
                                               - see ranibizumab 30(3) 79-82
legal issues                                                                                     Medicare (United States)
                                               lumiracoxib
- Disputes and dilemmas in health law -                                                          - cost of drugs (editorial) 32(4) 90-1
                                               - analgesia - Prexige (New drug) 29(1) 25-7
    book review 30(4) 105-6                                                                      medication reviews
                                               lung cancer
- Pharmacy law and ethics (book review)                                                          - collaboration between doctors and
                                               - angiogenesis inhibitors 29(1) 13-5
    33(5) 155                                                                                        pharmacists 33(6) 191-3
                                               - erlotinib - non-small cell lung cancer -
- publishing of drug evaluations (editorial)                                                     medicinal mishaps
                                                   Tarceva (New drug) 29(2) 53-5
    29(5) 120                                                                                    - bisphosphonates and osteonecrosis of the
                                               - thoracic computed tomography 32(4)
- - letter 30(2) 32-4                                                                                jaws 30(4) 96-7
                                                   105-7
lenalidomide                                                                                     - brand confusion with digoxin 29(6) 153
                                               lung diseases
- multiple myeloma - Revlimid (New drug)                                                         - cabergoline-induced valvulopathy 31(1) 21
                                               - management 30(3) 64-7
    31(2) 49-55                                                                                  - clindamycin and hepatotoxicity 32(5) 140
                                               - - letter - alpha-1-antitrypsin deficiency
- new drugs for multiple myeloma 32(4)                                                           - cross-reactivity of penicillins and
                                                   30(6) 140-1
    95-8                                                                                             cephalosporins 30(1) 25-6
                                               - patient support organisation 30(3) 79
leukaemia                                                                                        - dosing errors with infant drops 29(3) 83
                                               - thoracic computed tomography 32(4)
- alemtuzumab - chronic lymphocytic                                                              - fenofibrate-warfarin interaction 29(6) 166
                                                   105-7
    leukaemia - MabCampath (New drug)                                                            - interstitial nephritis and omeprazole 30(3)
                                               lung function tests
    29(6) 167-71                                                                                     67
                                               - Pocket guide (book review) 29(3) 70
- arsenic trioxide - acute promyelocytic                                                         - label confusion between Atropt and Azopt
                                               lymphoma
    leukaemia - Phenasen (New drug) 32(5)                                                            32(5) 138
                                               - plerixafor - Mozobil (New drug) 33(5)
    142-5                                                                                        - mirtazapine and hyponatraemia 31(4) 97
                                                   160-3
- azacitidine - myelodysplasia, leukaemia -                                                      - - letter 32(1) 5
                                               lysosomal storage diseases
    Vidaza (New drug) 33(3) 89-95                                                                - morphine dosages in acute pain 32(1) 13
                                               - galsulfase - mucopolysaccharidosis VI -
- clofarabine - paediatric acute lymphocytic                                                     - neutropenia with quetiapine 31(1) 10-1
                                                   Naglazyme (New drug) 31(5) 136-9
    leukaemia - Evoltra (New drug) 33(2)                                                         - serotonin syndrome and over-the-counter
                                               - idursulfase - Hunter syndrome - Elaprase
    52-9                                                                                             medicine 29(3) 71
                                                   (New drug) 31(4) 108-11
- dasatinib - chronic myeloid and acute                                                          - tamsulosin and floppy iris syndrome in
                                               - laronidase - mucopolysaccharidosis I -
    lymphoblastic leukaemia - Sprycel (New                                                           cataract surgery 33(3) 88-9
                                                   Aldurazyme (New drug) 30(3) 79-82
    drug) 30(2) 50-5




                                                                    -16-
Medicines Australia (see also under earlier     methicillin-resistant Staphylococcus              - - non-malignant disease 29(5) 130-3
    name APMA)                                      aureus                                        - in non-malignant disease 29(5) 130-3
- code of conduct breaches 33(6) 176; 32(6)     - multiresistant organisms 33(3) 68-71            - panitumumab - metastatic colorectal
    160-1; 31(6) 162-3; 30(6) 153-5; 29(6)      methotrexate                                          cancer - Vectibix (New drug) 31(5) 136-9
    164-5; 29(1) 16-7                           - management of patients taking                   - ranibizumab - macular degeneration -
- - letter 33(4) 101-2                              immunosuppressants 32(3) 68-71                    Lucentis (New drug) 30(3) 79-82
- - vardenafil 30(6) 154                        methoxy polyethylene glycol-epoetin beta          - rituximab - non-malignant disease 29(5)
Medicines Line                                  - anaemia in chronic kidney disease -                 130-3
- telephone information service                     Mircera (New drug) 32(6) 165-171              - tocilizumab - rheumatoid arthritis -
- - phonecalls about flu vaccination 33(1) 5    methylnaltrexone bromide                              Actemra (New drug) 32(4) 112-5
Medicines Safety Update                         - opioid-induced constipation - Relistor          - ustekinumab - psoriasis - Stelara (New
- adverse reactions information 33(1) 9;            (New drug) 32(1) 22-7                             drug) 33(2) 52-9
    33(1) 10-11                                 methylphenidate                                   monoclonal gammopathies
- AUST R and AUST L numbers 33(3) 80-3          - in attention deficit hyperactivity disorder     - multiple myeloma screening 32(4) 92-4
- cholinesterase inhibitors and syncope 33(5)       31(5) 129-32                                  morphine
    156-9                                       - - PBAC questions 31(3) 76                       - dosages in acute pain (medicinal mishap)
- contraceptive failure and etonogestrel        mifepristone                                          32(1) 13
    (Implanon)/carbamazepine interactions       - clinical overview 32(6) 152-4                   motion sickness
    33(6) 182-5                                 miglustat                                         - prevention in children 32(3) 61-3
- drug-induced acute akathisia 33(6) 182-5      - Zavesca - type 1 Gaucher disease and            mouth
- exenatide and pancreatitis 33(3) 80-3             Niemann-Pick disease type C (New drug)        - drug and radiotherapy-induced xerostomia
- fish oil and omega-3 fatty acids 33(2)            33(3) 89-95                                       29(4) 97-8
    48-51                                       - - correction 33(4) 131                          - - dental notes 29(4) 108
- influenza H1N1 vaccine (Panvax) 33(4)         migraine                                          - - letters 30(1) 3-4
    120-3                                       - and analgesic overuse                           - psychotropic drugs and dentistry 30(4)
- lamotrigine and skin reactions 33(6) 182-5    - - letter 29(3) 59-62                                98-101
- rivaroxaban (Xarelto) adverse events 33(5)    - eletriptan - Relpax (New drug) 33(6) 193-8      mouthwashes
    156-9                                       - rizatriptan - Maxalt (New drug) 33(2) 52-9      - role in oral hygiene 32(6) 162-4
- serotonin syndrome 33(6) 182-5                milk, human - see breastfeeding                   moxonidine
- sibutramine - obesity 33(3) 80-3              Mircera                                           - hypertension - Physiotens (New drug)
- statins, macrolides and rhabdomyolysis        - see methoxy polyethylene glycol-epoetin             29(1) 25-7
    33(5) 156-9                                     beta 32(6) 165-171                            mozobil
- uterine perforation and                       Mirena                                            - see plerixafor 33(5) 160-3
    levonorgestrel-releasing intrauterine       - see levonorgestrel 33(5) 156-9                  MRI - see magnetic resonance imaging
    system 33(5) 156-9                          mirtazapine                                       mucopolysaccharidosis I
- varenicline (Champix) and psychiatric         - mirtazapine-induced hyponatraemia               - laronidase - Aldurazyme (New drug) 30(3)
    symptoms 33(4) 120-3                            (medicinal mishap) 31(4) 97                       79-82
melanoma                                        - - letter 32(1) 5                                mucopolysaccharidosis II
- diagnostic tests 33(5) 150-5                  monoclonal antibodies                             - idursulfase - Elaprase (New drug) 31(4)
melatonin                                       - abciximab - non-malignant disease 29(5)             108-11
- primary insomnia - Circadin (New drug)            130-3                                         mucopolysaccharidosis VI
    33(2) 52-9                                  - alemtuzumab - chronic lymphocytic               - galsulfase - Naglazyme (New drug) 31(5)
melatonin analogues                                 leukaemia - MabCampath (New drug)                 136-9
- agomelatine - major depression - Valdoxan         29(6) 167-71                                  multiple myeloma
    (New drug) 33(5) 160-3                      - basiliximab - non-malignant disease 29(5)       - abnormal laboratory results 32(4) 92-4
memory disorders                                    130-3                                         - bortezomib - Velcade (New drug) 29(3)
- neurocognitive effects of chemotherapy        - certolizumab - rheumatoid arthritis -               84-7
    31(1) 22-4                                      Cimzia (New drug) 33(4) 129-131               - lenalidomide - Revlimid (New drug) 31(2)
menopause                                       - daclizumab - non-malignant disease 29(5)            49-55
- management of menopausal symptoms                 130-3                                         - new drugs 32(4) 95-8
    33(6) 171-5                                 - denosumab - osteoporosis - Prolia (New          - patient support organisation 32(4) 107
metformin                                           drug) 33(6) 193-8                             - plerixafor - Mozobil (New drug) 33(5)
- drugs for gestational diabetes 33(5) 141-4    - eculizumab - paroxysmal nocturnal                   160-3
- in pregnancy and lactation 30(3) 68-9             haemoglobinuria - Soliris (New drug)          multiple sclerosis
- safe use of radiographic contrast media           32(4) 112-5                                   - magnetic resonance imaging in
    33(1) 19-22                                 - golimumab - rheumatoid arthritis, psoriatic         neuroradiology 31(1) 18-20
- - letter 33(3) 64-7                               arthritis, ankylosing spondylitis - Simponi   - natalizumab - Tysabri (New drug) 30(4)
methadone                                           (New drug) 33(1) 22-7                             107-11
- dextromethorphan and serotonin syndrome       - muromonab - non-malignant disease 29(5)         muscle disorders
    (letter) 29(6) 149-50                           130-3                                         - statins, macrolides and rhabdomyolysis -
                                                - natalizumab                                         Medicines Safety Update 33(5) 156-9
                                                - - multiple sclerosis - Tysabri (New drug)
                                                    30(4) 107-11




                                                                     -17-
muscle spasticity                               neorotoxins                                       non-steroidal anti-inflammatory drugs -
- botulinum toxin 32(2) 39-42                   - botulinum toxin in muscle spasticity 32(2)          see anti-inflammatory drugs
myasthenia gravis                                   39-42                                         Noxafil
- Australian Myasthenic Association in          nephritis, interstitial                           - see posaconazole 29(3) 84-7
    NSW 30(6) 160                               - omeprazole adverse effects 30(3) 67             Nplate
- - patient support organisations in other      Neupro                                            - see romiplostim 31(6) 165-7
    states (letter) 31(3) 60-2                  - see rotigotine (New drug) 31(2) 49-55           NPS - see National Prescribing Service
- dental notes 30(6) 160                        neuralgia                                         NSAIDs - see anti-inflammatory drugs
- patient's perspective 30(6) 161               - drug treatment of neuropathic pain 29(3)        nuclear medicine
- treatment 30(6) 156-60                            72-5                                          - positron emission tomography 31(5) 123-8
- - letters 31(3) 60-2                          neuralgia, trigeminal                             number needed to treat
mycophenolate mofetil                           - patient support organisation 29(3) 75           - interpreting risks and ratios in clinical
- pharmacology of immunosuppressants            neuraminidase inhibitors                              trials 31(1) 12-6
    29(4) 99-101; 29(4) 102-8                   - antiviral drugs and influenza prophylaxis       nurse prescribers
myelodysplasia                                      (editorial) 30(2) 30-1                        - competency (editorial) 30(3) 58-9
- azacitidine - myelodysplasia, leukaemia -     neurology                                         - extended prescribing rights in the UK
    Vidaza (New drug) 33(3) 89-95               - magnetic resonance imaging in                       (editorial) 32(5) 118-9
myeloma - see multiple myeloma                      neuroradiology 31(1) 18-20                    - non-medical prescribing in Australia
myocardial infarction (see also coronary        - Therapeutic Guidelines - book reviews               (editorial) 33(6) 166-7
    disease)                                        30(4) 91                                      - prescribing (editorial) 30(1) 2-3
- eplerenone - Inspra (New drug)                neuromuscular blockade                            - - letters 31(1) 3-4; 30(4) 88-90
- - letter 29(2) 32-5                           - sugammadex - reversal of neuromuscular          nutrition - see diet
- omega-3-acid ethyl esters -                       blockade by rocuronium or vecuronium -
    hypertriglyceridaemia, secondary                Bridion (New drug) 32(3) 82-6                 O
    prevention - Omacor (New drug) 33(6)        neuropathic pain
    193-8                                       - drug treatment 29(3) 72-5
                                                                                                  obesity
- prasugrel - recurrent myocardial infarction   - - dental notes 29(3) 82
                                                                                                  - management 29(2) 43-7
    - Effient (New drug) 33(1) 22-7             neutraceuticals
                                                                                                  - sibutramine
Myozyme                                         - management of hypercholesterolaemia
                                                                                                  - - Medicines Safety Update 33(3) 80-3
- see alglucosidase alfa 31(3) 79-83                31(5) 119-22
                                                                                                  obstetrics
                                                neutropenia
                                                                                                  - carbetocin - prevention of uterine atony
N                                               - quetiapine (medicinal mishap) 31(1) 10-1
                                                                                                      after caesarian section - Duratocin (New
                                                New Zealand
                                                                                                      drug) 30(4) 107-11
                                                - direct-to-consumer advertising (editorial)
Naglazyme                                                                                         oesophagitis - see gastro-oesophageal
                                                    29(2) 30-2
- see galsulfase 31(5) 136-9                                                                          reflux
                                                - prescription drug subsidies (editorial)
nasal decongestants                                                                               olanzapine
                                                    33(1) 2-4
- over-the counter medications containing                                                         - in bipolar disorders 30(3) 70-3
                                                - - letters 33(3) 64-7
    the Sudafed label (letter) 32(3) 60                                                           - in pregnancy and breastfeeding 30(6)
                                                newborn
natalizumab                                                                                           162-3
                                                - caffeine citrate - apnoea of prematurity -
- multiple sclerosis - Tysabri (New drug)                                                         older persons - see aged
                                                    Cafnea (New drug) 33(3) 89-95
    30(4) 107-11                                                                                  olmesartan medoxomil
                                                - nitric oxide - neonatal respiratory failure -
National Prescribing Service                                                                      - hypertension - Olmetec (New drug) 30(3)
                                                    INOmax (New drug) 31(1) 24-7
- Therapeutic Advice and Information                                                                  79-82
                                                Nexavar
    Service (TAIS) 33(5) 147-9                                                                    Olmetec
                                                - see sorafenib 29(6) 167-71
nausea                                                                                            - see olmesartan medoxomil 30(3) 79-82
                                                nicotine
- fosaprepitant - cancer chemotherapy -                                                           Omacor
                                                - varenicline - Champix (New drug) 31(1)
    Emend IV (New drug) 31(4) 108-11                                                              - see omega-3-acid ethyl esters 33(6) 193-8
                                                    24-7
Nebilet                                                                                           omega-3 fatty acids
                                                - - letters 31(5) 115-8; 31(3) 60-2
- see nebivolol 33(4) 101-2; 33(4) 131;                                                           - Medicines Safety Update 33(2) 48-51
                                                Niemann-Pick disease
    33(2) 52-9                                                                                    omega-3-acid ethyl esters
                                                - miglustat - Niemann-Pick disease type C -
nebivolol                                                                                         - Omacor - hypertriglyceridaemia,
                                                    Zavesca (New drug) 33(3) 89-95
- hypertension, chronic heart failure -                                                               secondary prevention following
                                                nilotinib
    Nebilet (New drug) 33(2) 52-9                                                                     myocardial infarction (New drug) 33(6)
                                                - chronic myeloid leukaemia - Tasigna (New
- - correction 33(4) 131                                                                              193-8
                                                    drug) 31(2) 49-55
- - letter 33(4) 101-2                                                                            omeprazole
                                                nitisinone
necrosis                                                                                          - and interstitial nephritis 30(3) 67
                                                - hereditary tyrosinaemia type 1 - Orfadin
- spider bites 29(6) 156-8                                                                        Onbrez Breezhaler
                                                    (New drug) 32(2) 51-5
neonatal - see newborn                                                                            - see indacaterol 33(5) 160-3
                                                nitric oxide
NeoRecormon                                                                                       oncology - see cancer; antineoplastics
                                                - neonatal respiratory failure - INOmax
- see epoetin beta 29(4) 112-5                                                                    ophthalmic solutions
                                                    (New drug) 31(1) 24-7
                                                                                                  - correct use of eye drops 31(1) 16-7
                                                                                                  - - letter 31(4) 88-9




                                                                     -18-
opioids                                                                                        Parkinson's disease
- managing acute pain in opioid dependence      P                                              - pramipexole - Sifrol (New drug) 31(3)
    31(5) 133-5                                                                                    79-83
- methylnaltrexone bromide - opioid                                                            - rotigotine - Neupro (New drug) 31(2)
                                                paclitaxel
    analgesic-induced constipation - Relistor                                                      49-55
                                                - breast cancer (PBAC question) 30(1) 24-5
    (New drug) 32(1) 22-7                                                                      paroxetine
                                                paediatrics - see children
- neuropathic pain 29(3) 72-5                                                                  - selective serotonin reuptake inhibitors and
                                                pain
- in restless legs syndrome 31(4) 90-3                                                             suicide risk in children (editorial)
                                                - management in opioid dependence 31(5)
oral contraceptives - see contraceptives                                                       - - letter 29(2) 32-5
                                                    133-5
oral hygiene - see dental hygiene                                                              patents
                                                - management of dental and oral pain 30(3)
Orencia                                                                                        - evergreening drug patents (editorial) 29(6)
                                                    77-9
- see abatacept 30(6) 163-7                                                                        148-9
                                                - managing painful paediatric procedures
Orfadin                                                                                        - patent expiry and new drug approvals
                                                    29(4) 94-6; 29(4) 108
- see nitisinone 32(2) 51-5                                                                        (PBAC question) 32(3) 63
                                                - - letters 29(6) 149-50
orlistat                                                                                       pathology, diagnostic - see abnormal
                                                - morphine dosages in acute pain (medicinal
- management of obesity 29(2) 43-7                                                                 laboratory results
                                                    mishap) 32(1) 13
Orphan Drug Scheme                                                                             patient support organisations
                                                - neuropathic - drug treatment 29(3) 72-5
- rifampicin and MRSA infections (letter)                                                      - Anaphylaxis Australia 32(5) 128
                                                - - dental notes 29(3) 82
    29(1) 3-5                                                                                  - Australian Hepatitis Council 29(2) 39
                                                - paediatric analgesia 31(3) 63-5
osteoarthritis (see also arthritis)                                                            - Australian Lung Foundation 30(3) 79
                                                - - letters 31(6) 143-5
- etoricoxib - Arcoxia (New drug) 32(5)                                                        - Australian Myasthenic Association in
                                                paliperidone
    142-5                                                                                          NSW 30(6) 160
                                                - schizophrenia - Invega (New drug) 31(2)
- lumiracoxib - Prexige (New drug) 29(1)                                                       - - patient support organisations in other
                                                    49-55
    25-7                                                                                           states (letter) 31(3) 60-2
                                                palliative care
osteonecrosis                                                                                  - beyondblue (depression, postnatal
                                                - subsidised medicines 31(5) 132
- bisphosphonates and osteonecrosis of the                                                         depression, anxiety, bipolar disorder)
                                                - Therapeutic Guidelines - book review
    jaws 30(4) 96-7                                                                                31(2) 39
                                                    29(3) 79
- - letter 33(6) 167-170                                                                       - Continence Foundation of Australia 29(1)
                                                pancreatitis
osteoporosis                                                                                       24
                                                - exenatide - Medicines Safety Update 33(3)
- bisphosphonates                                                                              - Myeloma Foundation of Australia 32(4)
                                                    80-3
- - and osteonecrosis of the jaws 30(4) 96-7                                                       107
                                                pandemics
- - - letters 33(6) 167-170                                                                    - PANDA (perinatal depression) 31(2) 39
                                                - see disease outbreaks 30(2) 30-1
- corticosteroid-induced 31(2) 45-9                                                            - Psoriasis Australia 32(1) 18
                                                Pandemrix
- denosumab - Prolia (New drug) 33(6)                                                          - Trigeminal Neuralgia Association of
                                                - see influenza H5N1 vaccines 32(6)
    193-8                                                                                          Australia 29(3) 75
                                                    165-171
otitis media                                                                                   patient's perspective (see also patient
                                                panitumumab
- in childhood                                                                                     experiences)
                                                - metastatic colorectal cancer - Vectibix
- - management 32(6) 155-9                                                                     - deep vein thrombosis and flying 32(6)
                                                    (New drug) 31(5) 136-9
over-the-counter medicines                                                                         150-1
                                                Panvax H1N1 vaccine
- cold remedy precipitating serotonin                                                          - myasthenia gravis 30(6) 161
                                                - see influenza H1N1 vaccine 33(4) 120-3;
    syndrome 29(3) 71                                                                          pazopanib
                                                    32(6) 165-171
- - letter 29(6) 149-50                                                                        - Votrient - metastatic renal cell carcinoma
                                                papillomavirus vaccine
- cough and cold remedies in children 32(5)                                                        (New drug) 33(6) 193-8
                                                - Cervarix (New drug) 30(5) 133-5
    122-4                                                                                      PBAC - see Pharmaceutical Benefits
                                                - Gardasil (New drug) 29(5) 138-43
- medications containing the Sudafed label                                                         Advisory Committee
                                                paracetamol
    (letter) 32(3) 60                                                                          PBAC answers to questions
                                                - combination analgesics in adults 33(4)
- overdoses of anticholinergic drugs in                                                        - influenza vaccination 30(3) 83
                                                    113-5
    infantile colic 29(3) 83                                                                   - insulin prescribing in small quantities
                                                - gastrointestinal bleeding and hypertension
overactive bladder                                                                                 33(5) 144
                                                    (letter) 30(3) 59-63
- darifenacin hydrobromide - Enablex (New                                                      - patent expiry and new drug approvals
                                                - paediatric analgesia 31(3) 63-5
    drug) 29(5) 138-43                                                                             32(3) 63
                                                - - letter 31(6) 143-5
- solifenacin succinate - Vesicare - (New                                                      - rifampicin for MRSA infections 33(5)
                                                paraproteins
    drug) 29(5) 138-43                                                                             145-6
                                                - multiple myeloma screening 32(4) 92-4
overdose                                                                                       - specific drugs
                                                parathyroid hormone
- psychostimulant poisoning 29(4) 109-11                                                       - - adrenaline
                                                - management of renal bone disease 33(2)
overweight - see obesity                                                                       - - - shelf-life 29(2) 52-3
                                                    34-7
ovulation inducers - see fertility drugs                                                       - - methylphenidate and attention deficit
                                                - paricalcitol - secondary
oxybutynin                                                                                         hyperactivity disorder 31(3) 76
                                                    hyperparathyroidism - Zemplar (New
- overactive bladder 29(1) 22-4                                                                - - taxanes and breast cancer 30(1) 24-5
                                                    drug) 31(4) 108-11
                                                                                               PBS - see Pharmaceutical Benefits Scheme
                                                paricalcitol
                                                - secondary hyperparathyroidism - Zemplar
                                                    (New drug) 31(4) 108-11




                                                                    -19-
peginterferon alfa-2a/ribavirin                  - extended prescribing rights in the UK           plasma volume expanders
    combination                                      (editorial) 32(5) 118-9                       - pentastarch - Voluven (New drug) 30(4)
- hepatitis C 29(2) 36-9                         - non-medical prescribing in Australia                107-11
peginterferon alfa-2b/ribavirin                      (editorial) 33(6) 166-7                       plasma-derived products
    combination                                  - Pharmacy law and ethics (book review)           - safety 33(3) 76-9
- hepatitis C 29(2) 36-9                             33(5) 155                                     platelet antagonists
penicillin allergy                               pharmacogenetics                                  - cilostazol - intermittent claudication -
- cephalosporin cross-reactivity 30(1) 25-6      - warfarin pharmacogenetic testing 32(3)              Pletal (New drug) 32(3) 82-6
pentastarch                                          76-80                                         - clopidogrel response variability (editorial)
- hypovolaemia - Voluven (New drug) 30(4)        - - letter 32(5) 119-121                              33(3) 62-3
    107-11                                       pharmacokinetics                                  - coronary stents 30(4) 92-6
peptic ulcer                                     - clopidogrel response variability (editorial)    - prasugrel - recurrent myocardial infarction
- proton pump inhibitors - long-term                 33(3) 62-3                                        - Effient (New drug) 33(1) 22-7
    management 31(1) 5-7                         - generic drugs 30(2) 41-3                        plerixafor
peptides                                         - - letters 30(4) 88-90                           - Mozobil - lymphoma, multiple myeloma
- cyclic citrullinated antibodies in             - therapeutic drug monitoring - abnormal              (New drug) 33(5) 160-3
    rheumatoid arthritis 29(6) 162-4                 laboratory results 31(2) 42-4                 Pletal
perflutren                                       - - therapeutic range of digoxin (letter) 31(5)   - see cilostazol 32(3) 82-6
- ultrasound contrast medium - Definity              115-8                                         pneumococcal conjugate vaccine
    (New drug) 30(4) 107-11                      pharmacology - experimental and clinical          - Streptococcus pneumoniae infections -
perindopril                                          pharmacology                                      Synflorix (New drug) 33(2) 52-9
- patent evergreening (editorial) 29(6) 148-9    - angiogenesis inhibitors in cancer 29(1)         Pocket guide to lung function tests
periodontitis                                        9-12; 29(1) 13-5                              - book review 29(3) 70
- adverse drug effects 29(6) 154-5               - Goodman & Gilman's The                          point-of-care tests
- dental hygiene for adults 32(3) 72-5               pharmacological basis of therapeutics         - abnormal laboratory results 33(1) 6-9
- management of dental and oral pain 30(3)           (book review) 29(1) 25                        - - letter 33(6) 167-170
    77-9                                         - HIV fusion inhibitors 31(3) 66-9                - rapid diagnostic tests for influenza 32(3)
peripheral nervous system diseases               - immunosuppressants 29(4) 99-101; 29(4)              64-7
- prevention of foot ulcers 31(4) 94-6               102-8                                         poisoning
peripheral vascular diseases                     - incretins in diabetes 31(4) 102-4; 31(4)        - book review - Therapeutic Guidelines:
- prevention of foot ulcers 31(4) 94-6               104-8                                             Toxicology & Wilderness 31(6) 164-5
personal experiences of illness - see            - oral anticoagulants 33(2) 38-41; 33(2) 42-7     - management of injuries by sea creatures
    patient's perspective                        - renin inhibitors 32(5) 132-5; 32(5) 135-8           30(5) 117-21
pertussis                                        - warfarin pharmacogenetic testing 32(3)          - - letter 31(2) 32
- management in adults 32(2) 36-8                    76-80                                         - snake bites 29(5) 125-9
PET - see positron emission tomography           - - letter 32(5) 119-121                          - spider bites 29(6) 156-8
Pharmaceutical Benefits Scheme                   Phenasen                                          polypharmacy
- comparisons with US Medicare program           - see arsenic trioxide 32(5) 142-5                - editorial 31(1) 2-3
    (editorial) 32(4) 90-1                       phenylephrine                                     Pompe disease
- drug price reforms (editorial) 30(6) 138-40    - over-the counter medications containing         - alglucosidase alfa - Myozyme (New drug)
- expensive drugs (editorial) 29(6) 146-8            the Sudafed label (letter) 32(3) 60               31(3) 79-83
- - letter 30(3) 59-63                           phosphate binders                                 posaconazole
- non-medical prescribing in Australia           - lanthanum carbonate hydrate -                   - fungal infections - Noxafil (New drug)
    (editorial) 33(6) 166-7                          hyperphosphataemia in chronic renal               29(3) 84-7
- prescription drug pricing 32(1) 6-8                failure - Fosrenol (New drug) 29(2) 53-5      positron emission tomography
- - letter 32(3) 60                              - management of renal bone disease 33(2)          - diagnostic tests 31(5) 123-8
- prescription drug subsidies in Australia and       34-7                                          postmenopausal symptoms - see
    New Zealand (editorial) 33(1) 2-4            phosphodiesterase inhibitors                          menopause
- - letters 33(3) 64-7                           - cilostazol - intermittent claudication -        practice incentives
- subsidised medicines for Aboriginal people         Pletal (New drug) 32(3) 82-6                  - in restless legs syndrome 31(4) 90-3
    32(5) 121; 31(4) 89                          physical activity                                 Pradaxa
- subsidised palliative care medicines 31(5)     - lifestyle management of hypertension            - see dabigatran etexilate 32(2) 51-5
    132                                              31(6) 150-3                                   pramipexole
pharmaceutical industry - see drug               Physiotens                                        - Parkinson's disease, restless legs syndrome
    industry                                     - see moxonidine 29(1) 25-7                           - Sifrol (New drug) 31(3) 79-83
pharmaceutical promotion - see                   pilocarpine                                       - in restless legs syndrome 31(4) 90-3
    advertising                                  - management of xerostomia 29(4) 97-8             prasugrel
pharmacists                                      - - letters 30(1) 3-4                             - recurrent myocardial infarction - Effient
- collaboration with doctors 33(6) 191-3         pituitary cancer                                      (New drug) 33(1) 22-7
- drug compounding in community                  - drug treatment 32(1) 19-21                      pre-eclampsia
    pharmacy (editorial) 31(2) 30-1                                                                - biochemical tests for abnormalities in
- - letter 31(5) 115-8                                                                                 pregnancy (letter) 29(4) 91-3




                                                                      -20-
prednisone                                      pseudoephedrine
- in myasthenia gravis 30(6) 156-60             - in myasthenia gravis (letter) 31(3) 60-2        R
pregnancy (see also birth defects,              - over-the counter medications containing
    breastfeeding)                                  the Sudafed label (letter) 32(3) 60
                                                                                                  rabies vaccine
- abnormal laboratory results - biochemical     psoriasis
                                                                                                  - Rabipur (New drug) 29(1) 25-7
    tests                                       - dental notes 32(1) 18
                                                                                                  Rabipur
- - letters 29(1) 3-5                           - golimumab - psoriatic arthritis - Simponi
                                                                                                  - see rabies vaccine 29(1) 25-7
- anticonvulsants 31(3) 70-2                        (New drug) 33(1) 22-7
                                                                                                  radiography
- antidepressants 30(5) 125-7                   - management of severe psoriasis 32(1) 14-8
                                                                                                  - safe use of contrast media 33(1) 19-22
- - letter 31(2) 32                             - - update: withdrawal of efalizumab 32(2)
                                                                                                  - - letter 33(3) 64-7
- antipsychotics 30(6) 162-3                        50
                                                                                                  radiotherapy
- biochemical tests for abnormalities 29(2)     - patient support organisations 32(1) 18
                                                                                                  - salivary glands and xerostomia 29(4) 97-8
    48-52                                       - tazarotene - Zorac (New drug) 29(3) 84-7
                                                                                                  - - dental notes 29(4) 108
- - letter 29(4) 91-3                           - ustekinumab - Stelara (New drug) 33(2)
                                                                                                  - - letters 30(1) 3-4
- drugs for gestational diabetes 33(5) 141-4        52-9
                                                                                                  raltegravir
- metformin and diabetes 30(3) 68-9             psychotic disorders
                                                                                                  - HIV infection - Isentress (New drug) 31(2)
- patient support organisations - perinatal     - long-term community management 30(2)
                                                                                                      49-55
    depression 31(2) 39                             44-6
                                                                                                  ranibizumab
- restless legs syndrome (letter) 31(6) 143-5   psychotropic drugs
                                                                                                  - macular degeneration - Lucentis (New
- thyroid replacement therapy 31(6) 159-61      - attention deficit hyperactivity disorder
                                                                                                      drug) 30(3) 79-82
- treatment of perinatal depression 31(2)           31(5) 129-32
                                                                                                  Rational Assessment of Drugs and
    36-9                                        - and dentistry 30(4) 98-101
                                                                                                      Research (RADAR) - see RADAR
premature infants                               - Therapeutic Guidelines: Psychotropic
                                                                                                  reference pricing
- caffeine citrate - apnoea of prematurity -        (book reviews) 32(2) 42
                                                                                                  - drug price reforms (editorial) 30(6) 138-40
    Cafnea (New drug) 33(3) 89-95               public health
                                                                                                  Relistor
prescribing patterns, costs, etc. - see drug    - climate change and infectious diseases
                                                                                                  - see methylnaltrexone bromide 32(1) 22-7
    utilisation; cost of drugs                      (editorial) 32(3) 58-9
                                                                                                  Relpax
Prexige                                         - funding of influenza vaccination for
                                                                                                  - see eletriptan 33(6) 193-8
- see lumiracoxib 29(1) 25-7                        healthy adults 30(2) 35-7
                                                                                                  renal - see kidney
Prezista                                        - - letter 30(5) 116
                                                                                                  renal cell carcinoma
- see darunavir 30(3) 79-82                     pulmonary disease, chronic obstructive
                                                                                                  - pazopanib - Votrient (New drug) 33(6)
price of drugs - see cost of drugs              - indacaterol - Onbrez Breezhaler (New
                                                                                                      193-8
Primovist                                           drug) 33(5) 160-3
                                                                                                  renin inhibitors
- see disodium gadoxetate 29(3) 84-7            - management 30(3) 64-7
                                                                                                  - in hypertension 32(5) 135-8
Pristiq                                         - - letter - alpha-1-antitrypsin deficiency
                                                                                                  - - letter 33(3) 64-7
- see desvenlafaxine 32(1) 22-7                     30(6) 140-1
                                                                                                  - pharmacology 32(5) 132-5
progesterone                                    - patient support organisations 30(3) 79
                                                                                                  respiration disorders
- inhibitors - mifepristone 32(6) 152-4         pulmonary hypertension
                                                                                                  - arterial blood gases - abnormal laboratory
prolactinoma                                    - ambrisentan - Volibris (New drug) 33(1)
                                                                                                      results 33(4) 124-9
- drug treatment of pituitary tumours 32(1)         22-7
                                                                                                  - caffeine citrate - apnoea of prematurity -
    19-21                                       - nitric oxide - neonatal respiratory failure -
                                                                                                      Cafnea (New drug) 33(3) 89-95
Prolia                                              INOmax (New drug) 31(1) 24-7
                                                                                                  - nitric oxide - neonatal respiratory failure -
- see denosumab 33(6) 193-8                     - sitaxentan - Thelin (New drug) 31(3) 79-83
                                                                                                      INOmax (New drug) 31(1) 24-7
prostatic cancer                                pulmonary rehabilitation
                                                                                                  - Therapeutic Guidelines - book reviews
- degarelix - Firmagon (New drug) 33(6)         - chronic obstructive pulmonary disease
                                                                                                      33(2) 47
    193-8                                           30(3) 64-7
                                                                                                  restless legs syndrome
- triptorelin embonate - anti-androgen -        purpura
                                                                                                  - cabergoline-induced valvulopathy
    Diphereline (New drug) 32(1) 22-7           - romiplostim - idiopathic thrombocytopenic
                                                                                                      (medicinal mishap) 31(1) 21
prostatic hypertrophy, benign                       purpura - Nplate (New drug) 31(6) 165-7
                                                                                                  - diagnosis and management 31(4) 90-3
- alfuzosin - Xatral SR (New drug) 33(2)        pyridostigmine
                                                                                                  - - in pregnancy (letter) 31(6) 143-5
    52-9                                        - in myasthenia gravis 30(6) 156-60
                                                                                                  - pramipexole - Sifrol (New drug) 31(3)
- dutasteride - Avodart (New drug) 32(4)
                                                                                                      79-83
    112-5                                       Q                                                 - in pregnancy (letter) 31(6) 143-5
protein C
                                                                                                  Retaane
- congenital protein C deficiency - Ceprotin
                                                QTc interval - see arrhythmia                     - see anecortave 29(2) 53-5
    (New drug) 30(2) 50-5
                                                quality use of medicines - see drug               retinal disease
proton pump inhibitors
                                                   information; drug therapy; drug                - macular degeneration - anecortave -
- interactions with clopidogrel (editorial)
                                                   utilisation                                        Retaane (New drug) 29(2) 53-5
    33(3) 62-3
                                                quetiapine                                        retinoids
- long-term management 31(1) 5-7
                                                - neutropenia (medicinal mishap) 31(1) 10-1       - tazarotene - psoriasis, acne - Zorac (New
- omeprazole and interstitial nephritis 30(3)
                                                                                                      drug) 29(3) 84-7
    67




                                                                     -21-
Revlimid                                        romiplostim                                      serotonin syndrome
- see lenalidomide 31(2) 49-55                  - idiopathic thrombocytopenic purpura -          - Medicines Safety Update 33(6) 182-5
rhabdomyolysis                                     Nplate (New drug) 31(6) 165-7                 - over-the-counter dextromethorphan 29(3)
- statins and macrolides interactions -         ropinirole                                           71
    Medicines Safety Update 33(5) 156-9         - in restless legs syndrome 31(4) 90-3           - - letter 29(6) 149-50
rheumatoid arthritis                            rosuvastatin                                     sexually transmitted infections
- abatacept - Orencia (New drug) 30(6)          - hypercholesterolaemia - Crestor (New           - abnormal laboratory results 30(1) 8-13
    163-7                                          drug) 29(6) 167-71                            shingles
- abnormal laboratory results - antibodies to   Rotarix                                          - zoster virus vaccine - Zostavax (New drug)
    cyclic citrullinated peptides 29(6) 162-4   - see rotavirus vaccine 29(4) 112-5                  31(1) 24-7
- certolizumab - Cimzia (New drug) 33(4)        RotaTeq                                          sialogogues
    129-131                                     - see rotavirus vaccine 29(4) 112-5              - management of xerostomia 29(4) 97-8
- tocilizumab - Actemra (New drug) 32(4)        rotavirus vaccine                                - - letters 30(1) 3-4
    112-5                                       - Rotarix (New drug) 29(4) 112-5                 sibutramine
rheumatoid factor                               - RotaTeq (New drug) 29(4) 112-5                 - obesity
- abnormal laboratory results - rheumatoid      rotigotine                                       - - management 29(2) 43-7
    arthritis 29(6) 162-4                       - Parkinson's disease - Neupro (New drug)        - - Medicines Safety Update 33(3) 80-3
rheumatology (see also arthritis;                  31(2) 49-55                                   Sifrol
    anti-inflammatory drugs)                    rural health                                     - see pramipexole 31(3) 79-83
- NSAIDs and cardiovascular disease             - undertreatment of cardiovascular diseases      Simponi
    (editorial) 29(4) 90-1                         (editorial) 31(4) 86-7                        - see golimumab 33(1) 22-7
- Therapeutic Guidelines - book review                                                           sirolimus
    29(5) 124                                   S                                                - pharmacology of immunosuppressants
- tumour necrosis factor blockers 29(3)                                                              29(4) 99-101; 29(4) 102-8
    67-70                                                                                        sitagliptin
                                                salivary glands
- - risk of malignancy (letter) 31(3) 60-2                                                       - clinical applications of incretins 31(4)
                                                - drug- and radiotherapy-induced xerostomia
ribavirin                                                                                            104-8
                                                    29(4) 97-8
- peginterferon/ribavirin combination in                                                         - type 2 diabetes - Januvia (New drug) 31(2)
                                                - - dental notes 29(4) 108
    hepatitis C 29(2) 36-9                                                                           49-55
                                                - - letters 30(1) 3-4
rifampicin                                                                                       - - letter 31(3) 60-2
                                                salmeterol
- MRSA infections (PBAC question) 33(5)                                                          sitaxentan
                                                - safety concerns (editorial) 29(5) 118-9
    145-6                                                                                        - pulmonary hypertension - Thelin (New
                                                schizophrenia
- MRSA infections - Orphan Drug Scheme                                                               drug) 31(3) 79-83
                                                - long-term community management 30(2)
    (letter) 29(1) 3-5                                                                           skin cancer
                                                    44-6
risk                                                                                             - melanoma - diagnostic tests 33(5) 150-5
                                                - paliperidone - Invega (New drug) 31(2)
- interpreting risks and ratios in clinical                                                      skin diseases
                                                    49-55
    trials 31(1) 12-6                                                                            - lamotrigine and serious skin reactions -
                                                - ziprasidone - Zeldox (New drug) 30(2)
- pharmacotherapy for risk factors 30(2)                                                             Medicines Safety Update 33(6) 182-5
                                                    50-5
    47-50                                                                                        skin infections
                                                - - letter 30(3) 59-63
- - letter 30(4) 88-90                                                                           - daptomycin - Cubicin (New drug) 32(2)
                                                seafood
risperidone                                                                                          51-5
                                                - 'iodine allergy' 32(5) 125-8
- paliperidone - risperidone metabolite -                                                        skin testing
                                                - - letter 33(3) 64-7
    schizophrenia - Invega (New drug) 31(2)                                                      - tuberculosis diagnosis 33(1) 12-18
                                                Sebivo
    49-55                                                                                        sleep disorders (see also insomnia)
                                                - see telbivudine 30(6) 163-7
rivaroxaban                                                                                      - restless legs syndrome 31(4) 90-3
                                                sedatives
- adverse events - Medicines Safety Update                                                       - - letter 31(6) 143-5
                                                - psychotropic drugs and dentistry 30(4)
    33(5) 156-9                                                                                  sleep-related behaviour
                                                    98-101
- new oral anticoagulants in hip and knee                                                        - adverse effects of zolpidem and zopiclone
                                                serotonin agonists
    arthroplasty 33(2) 42-7                                                                          31(6) 146-9
                                                - eletriptan - migraine - Relpax (New drug)
- - letter 33(6) 167-170                                                                         smallpox
                                                    33(6) 193-8
- pharmacology of new oral anticoagulants                                                        - vaccinia vaccine - ACAM2000 (New drug)
                                                - rizatriptan - migraine - Maxalt (New drug)
    33(2) 38-41                                                                                      32(6) 165-171
                                                    33(2) 52-9
- prevention of postoperative venous                                                             smoking cessation
                                                serotonin reuptake inhibitors (see also
    thrombosis - Xarelto (New drug) 32(1)                                                        - lifestyle management of hypertension
                                                    antidepressant drugs)
    22-7                                                                                             31(6) 150-3
                                                - antidepressants and suicide risk in children
rizatriptan benzoate                                                                             - varenicline (Champix) and psychiatric
                                                    (editorials)
- migraine - Maxalt (New drug) 33(2) 52-9                                                            symptoms - Medicines Safety Update
                                                - - letter 29(2) 32-5
road safety                                                                                          33(4) 120-3
                                                - desvenlafaxine - Pristiq (New drug) 32(1)
- drug therapy and drug abuse 31(2) 33-5                                                         - varenicline - Champix (New drug) 31(1)
                                                    22-7
rocuronium bromide                                                                                   24-7
                                                - pregnancy and breastfeeding 30(5) 125-7
- sugammadex - reversal of neuromuscular                                                         - - letters 31(5) 115-8; 31(3) 60-2
                                                - - letter 31(2) 32
    blockade - Bridion (New drug) 32(3) 82-6




                                                                     -22-
snake bites                                   sugammadex                                      teratogens - see birth defects
- management 29(5) 125-9                      - reversal of neuromuscular blockade by         testosterone 5-alpha reductase inhibitors
sodium valproate                                  rocuronium or vecuronium - Bridion          - dutasteride - benign prostatic hyperplasia -
- see valproic acid 30(3) 70-3                    (New drug) 32(3) 82-6                           Avodart (New drug) 32(4) 112-5
solifenacin succinate                         suicide                                         tetanus vaccine
- overactive bladder - Vesicare (New drug)    - risk in children (editorials)                 - management of animal and human bites
    29(5) 138-43                              - - letter 29(2) 32-5                               29(1) 6-8
Soliris                                       sulfonamides                                    thalassaemia
- see eculizumab 32(4) 112-5                  - allergy and cross-reactivity 31(1) 8-10       - deferasirox - chelating agent - Exjade
somatostatin analogues                        - - letters 32(2) 31; 31(4) 88-9                    (New drug) 29(4) 112-5
- in pituitary tumours and acromegaly 32(1)   sulfur                                          thalidomide (see also lenalidomide)
    19-21                                     - allergy and cross-reactivity 31(1) 8-10       - angiogenesis inhibitors in cancer 29(1)
sorafenib                                     - - letters 31(4) 88-9                              9-12
- renal cell cancer 29(6) 151-3               sunitinib                                       - new drugs for multiple myeloma 32(4)
- renal cell cancer - Nexavar (New drug)      - gastrointestinal stromal tumour, renal cell       95-8
    29(6) 167-71                                  cancer - Sutent (New drug) 29(6) 167-71     Thelin
spider bites                                  - renal cell cancer 29(6) 151-3                 - see sitaxentan (New drug) 31(3) 79-83
- management 29(6) 156-8                      surgery                                         Therapeutic Advice and Information
spondylitis, ankylosing                       - new oral anticoagulants in hip and knee           Service
- golimumab - Simponi (New drug) 33(1)            arthroplasty 33(2) 38-41                    - TAIS - 33(5) 147-9
    22-7                                      - - letter 33(6) 167-170                        Therapeutic Goods Administration
Sprycel                                       - pharmacology of new oral anticoagulants       - AUST R and AUST L numbers -
- see dasatinib 30(2) 50-5                        in arthroplasty 33(2) 38-41                     Medicines Safety Update 33(3) 80-3
St John's wort                                surrogate outcome markers                       - Medicines Safety Update 33(1) 10-11
- drug interactions 33(6) 177-80              - clinical trials 32(2) 47-50                   - rifampicin and MRSA infections - Orphan
staphylococcal infections                     Sutent                                              Drug Scheme (letter) 29(1) 3-5
- community-acquired methicillin-resistant    - see sunitinib 29(6) 167-71                    - transparency of regulatory drug
    infection                                 syncope                                             information (editorial) 31(5) 114-5
- - letter 29(3) 59-62                        - cholinesterase inhibitors - Medicines         Therapeutic Guidelines
- daptomycin - Staphylococcus aureus              Safety Update 33(5) 156-9                   - book reviews
    bacteraemia - Cubicin (New drug) 32(2)    Synflorix                                       - - Analgesic 31(2) 39
    51-5                                      - see pneumococcal conjugate vaccine 33(2)      - - Antibiotic 30(3) 73
- methicillin resistance 33(3) 68-71              52-9                                        - - Cardiovascular 31(6) 158
- rifampicin and MRSA infections (PBAC        syphilis                                        - - Dermatology 32(5) 139
    question) 33(5) 145-6                     - abnormal laboratory results 30(1) 8-13        - - Endocrinology 32(6) 151
- rifampicin and MRSA infections - Orphan                                                     - - Gastrointestinal 30(2) 46
    Drug Scheme (letter) 29(1) 3-5            T                                               - - Neurology 30(4) 91
starter packs                                                                                 - - Oral and Dental 30(4) 106
- adverse effects 30(1) 14-6                                                                  - - Palliative care 29(3) 79
                                              tacrolimus
statins - see antilipidaemic drugs                                                            - - Psychotropic 32(2) 42
                                              - pharmacology of immunosuppressants
statistics                                                                                    - - Respiratory 33(2) 47
                                                 29(4) 99-101
- interpreting risks and ratios in clinical                                                   - - Rheumatology 29(5) 124
                                              TAIS - see Therapeutic Advice and
    trials 31(1) 12-6                                                                         - - Toxicology & Wilderness 31(6) 164-5
                                                 Information Service
Stelara                                                                                       - PDA review - Mini TG (personal digital
                                              tamsulosin hydrochloride
- see ustekinumab 33(2) 52-9                                                                      assistant version) 29(1) 21
                                              - and floppy iris syndrome in cataract
stem cell transplantation                                                                     therapeutic guidelines
                                                 surgery - medicinal mishap 33(3) 88-9
- adult leukaemia 29(3) 76-9                                                                  - antibiotics and endocarditis - dental notes
                                              Tarceva
steroids - see corticosteroids                                                                    31(6) 153
                                              - see erlotinib 29(2) 53-5
Stevens-Johnson syndrome                                                                      - turning knowledge into action (editorial)
                                              Tasigna
- lamotrigine and serious skin reactions -                                                        30(5) 114-5
                                              - see nilotinib 31(2) 49-55
    Medicines Safety Update 33(6) 182-5                                                       thiazolidinediones
                                              taxanes
stingrays                                                                                     - adverse effects in diabetes (editorial) 31(3)
                                              - breast cancer (PBAC question) 30(1) 24-5
- management of stings 30(5) 117-21                                                               58-9
                                              tazarotene
- - letter 31(2) 32                                                                           thrombocytopenia
                                              - psoriasis, acne - Zorac (New drug) 29(3)
stress testing                                                                                - idiopathic thrombocytopenic purpura -
                                                 84-7
- diabetes - exercise 30(5) 130-3                                                                 romiplostim - Nplate (New drug) 31(6)
                                              telbivudine
stroke - see cerebrovascular disorders                                                            165-7
                                              - chronic hepatitis B - Sebivo (New drug)
Sudafed                                                                                       thromboembolism
                                                 30(6) 163-7
- over-the counter medications containing                                                     - antiplatelet therapy after coronary stents
                                              temsirolimus
    the Sudafed label (letter) 32(3) 60                                                           30(4) 92-6
                                              - renal cell carcinoma - Torisel (New drug)
                                                                                              - compression therapy 33(6) 186-90
                                                 31(4) 108-11




                                                                  -23-
- dabigatran etexilate - prevention of           transplantation (see also specific organs)        ultrasound
    postoperative venous thrombosis -            - immunosuppressants 29(4) 102-8                  - deep venous thrombosis 30(2) 38-40
    Pradaxa (New drug) 32(2) 51-5                travel                                            - echocardiography 29(5) 134-8
- diagnosis of recurrent deep venous             - climate change and infectious diseases          - - letter 30(1) 3-4
    thrombosis 30(2) 38-40                           (editorial) 32(3) 58-9                        - perflutren - contrast medium - Definity
- flying 32(6) 148-50                            - motion sickness prevention in children              (New drug) 30(4) 107-11
- - letters 33(2) 32-3; 33(2) 32-3; 33(2) 32-3       32(3) 61-3                                    United Kingdom
- - patient's perspective 32(6) 150-1            - overseas travel and medicines 29(3) 80-2        - extended prescribing rights (editorial)
- heparins in venous thromboembolism             - thromboembolism and flying (patient's               32(5) 118-9
    prophylaxis 32(4) 108-12                         perspective) 32(6) 150-1                      United States
- - letter 33(6) 167-170                         - thromboembolism risk, prophylaxis and           - cost of drugs and the Medicare program
- new oral anticoagulants in hip and knee            flying 32(6) 148-50                               (editorial) 32(4) 90-1
    arthroplasty 33(2) 42-7                      - - letters 33(2) 32-3; 33(2) 32-3; 33(2) 32-3    urinary incontinence
- - letter 33(6) 167-170                         tricyclic antidepressants - see                   - anticholinergic drugs 29(1) 22-4
- pharmacology of new oral anticoagulants            antidepressant drugs                          - - letter 29(4) 91-3
    33(2) 38-41                                  trigeminal neuralgia                              ustekinumab
- rivaroxaban - prevention of postoperative      - patient support organisation 29(3) 75           - psoriasis - Stelara (New drug) 33(2) 52-9
    venous thrombosis - Xarelto (New drug)       triptorelin embonate                              uterine perforation
    32(1) 22-7                                   - anti androgen - prostate cancer -               - and levonorgestrel-releasing intrauterine
thrombolytic drugs - see fibrinolytic                Diphereline (New drug) 32(1) 22-7                 system - Medicines Safety Update 33(5)
    drugs; anticoagulants                        tropical diseases                                     156-9
Thymoglobuline                                   - climate change and infectious diseases
- see anti-thymocyte globulin 31(5) 136-9            (editorial) 32(3) 58-9                        V
thyroid function tests                           tuberculosis
- abnormal laboratory results in pregnancy       - diagnostic tests 33(1) 12-18
                                                                                                   vaccination (see also injections)
- - letter 29(1) 3-5                             tumour necrosis factor
                                                                                                   - human papillomavirus
thyroxine                                        - monoclonal antibodies 29(5) 130-3
                                                                                                   - - Cervarix (New drug) 30(5) 133-5
- shelf-life and refrigeration (letters) 29(2)   tumour necrosis factor blockers
                                                                                                   - - Gardasil (New drug) 29(5) 138-43
    32-5                                         - golimumab - rheumatoid arthritis, psoriatic
                                                                                                   - influenza H1N1 vaccine
- thyroid replacement therapy 31(6) 159-61           arthritis, ankylosing spondylitis - Simponi
                                                                                                   - - editorial 33(2) 30-1
tigecycline                                          (New drug) 33(1) 22-7
                                                                                                   - - - letters 33(3) 64-7
- complicated infections - Tygacil (New          - rheumatoid arthritis 29(3) 67-70
                                                                                                   - - letter 33(1) 5
    drug) 29(5) 138-43                           - risk of malignancy (letter) 31(3) 60-2
                                                                                                   - - Panvax and Panvax Junior - Medicines
tinnitus                                         Tygacil
                                                                                                       Safety Update 33(4) 120-3
- Ginkgo biloba (editorial) 29(5) 120            - see tigecycline 29(5) 138-43
                                                                                                   - - Panvax H1N1 vaccine (New drug) 32(6)
- - letter 30(2) 32-4                            Tykerb
                                                                                                       165-171
tipranavir                                       - see lapatinib 30(5) 133-5
                                                                                                   - influenza H5N1 vaccines - Pandemrix,
- HIV infection - Aptivus (New drug) 30(4)       tyrosinaemia
                                                                                                       Panvax and Emerflu (New drugs) 32(6)
    107-11                                       - nitisinone - hereditary tyrosinaemia type 1
                                                                                                       165-171
tocilizumab                                          - Orfadin (New drug) 32(2) 51-5
                                                                                                   - influenza seasonal vaccine - Intanza (New
- rheumatoid arthritis - Actemra (New drug)      tyrosine kinase inhibitors
                                                                                                       drug) 32(6) 165-171
    32(4) 112-5                                  - dasatinib - chronic myeloid and acute
                                                                                                   - influenza vaccination for healthy adults
tolterodine                                          lymphoblastic leukaemia - Sprycel (New
                                                                                                       30(2) 35-7
- overactive bladder 29(1) 22-4                      drug) 30(2) 50-5
                                                                                                   - - letter 30(5) 116
- - letter 29(4) 91-3                            - lapatinib - breast cancer - Tykerb (New
                                                                                                   - - PBAC question 30(3) 83
tomography, X-ray computed                           drug) 30(5) 133-5
                                                                                                   - Japanese encephalitis
- thoracic 32(4) 105-7                           - nilotinib - chronic myeloid leukaemia -
                                                                                                   - - Jespect (New drug) 32(3) 82-6
tooth - see dental, dentistry                        Tasigna (New drug) 31(2) 49-55
                                                                                                   - managing painful paediatric procedures
toothbrushing                                    - renal cell cancer 29(6) 151-3
                                                                                                       29(4) 94-6
- for adults 32(3) 72-5                          - sorafenib - renal cell cancer - Nexavar
                                                                                                   - pertussis - adult and adolescent
top 10 drugs                                         (New drug) 29(6) 167-71
                                                                                                       immunisation 32(2) 36-8
- statistics 33(6) 181; 32(6) 159; 31(6) 164;    - sunitinib - gastrointestinal stromal tumour,
                                                                                                   - pneumococcal conjugate vaccine
    30(6) 142; 29(6) 167; 29(1) 5                    renal cell cancer - Sutent (New drug)
                                                                                                   - - Streptococcus pneumoniae infections -
Torisel                                              29(6) 167-71
                                                                                                       Synflorix (New drug) 33(2) 52-9
- see temsirolimus 31(4) 108-11                  Tysabri
                                                                                                   - rabies - Rabipur (New drug) 29(1) 25-7
toxicology                                       - see natalizumab 30(4) 107-11
                                                                                                   - rotavirus vaccine - Rotarix (New drug)
- book review - Therapeutic Guidelines:
                                                                                                       29(4) 112-5
    Toxicology & Wilderness 31(6) 164-5          U                                                 - rotavirus vaccine - RotaTeq (New drug)
transparency of information about new
                                                                                                       29(4) 112-5
    drugs - see drug evaluation; drug
                                                 ulcers                                            - tetanus vaccine in management of animal
    regulation
                                                 - foot infections in diabetes 30(1) 21-4              and human bites 29(1) 6-8
                                                 - prevention of foot ulcers 31(4) 94-6




                                                                      -24-
- vaccinia smallpox vaccine - ACAM2000            venous diseases                                  wound infections
    (New drug) 32(6) 165-171                      - compression therapy 33(6) 186-90               - management of animal and human bites
- varicella                                       venous thrombosis - see thromboembolism              29(1) 6-8
- - vaccination (letter) 30(5) 116                Vesicare                                         - - letters 29(3) 59-62
- zoster virus vaccine - Zostavax (New drug)      - see solifenacin succinate 29(5) 138-43         wounds
    31(1) 24-7                                    Vidaza                                           - managing painful paediatric procedures
vaccinia smallpox vaccine                         - see azacitidine 33(3) 89-95                        29(4) 94-6
- ACAM2000 (New drug) 32(6) 165-171               vildagliptin                                     - - letters 29(6) 149-50
Valdoxan                                          - clinical applications of incretins 31(4)
- see agomelatine 33(5) 160-3                         104-8                                        X
Valette                                           - Galvus - type 2 diabetes (New drug) 33(3)
- see dienogest/ethinyloestradiol 30(2) 50-5          89-95
                                                                                                   xanthopsia
valproic acid                                     Vimpat
                                                                                                   - digoxin dosages 29(6) 153
- in bipolar disorders 30(3) 70-3                 - see lacosamide 33(1) 22-7
                                                                                                   Xarelto
- in pregnancy and breastfeeding 31(3) 70-2       vision disorders
                                                                                                   - see rivaroxaban 33(5) 156-9; 32(1) 22-7
valsartan                                         - xanthopsia and digoxin dosages 29(6) 153
                                                                                                   Xatral SR
- with amlodipine - hypertension - Exforge        vitamin D
                                                                                                   - see alfuzosin 33(2) 52-9
    (New drug) 32(1) 22-7                         - deficiency
                                                                                                   xerostomia
- with hydrochlorothiazide - hypertension -       - - dental notes 33(4) 107
                                                                                                   - drug- and radiotherapy-induced 29(4) 97-8
    Co-Diovan (New drug) 32(1) 22-7               - - management in adults 33(4) 103-6
                                                                                                   - - dental notes 29(4) 97-8
- hypertension, heart failure - Diovan (New       - management of renal bone disease 33(2)
                                                                                                   - - letters 30(1) 3-4
    drug) 32(1) 22-7                                  34-7
                                                                                                   - psychotropic drugs and dentistry 30(4)
Vaniqa                                            - prevention of corticosteroid-induced bone
                                                                                                       98-101
- see eflornithine hydrochloride 29(3) 84-7           loss 31(2) 45-9
vardenafil                                        vitamin K
- advertising - Medicines Australia code of       - anticonvulsants in pregnancy and               Y
    conduct breaches 30(6) 154                        breastfeeding 31(3) 70-2
varenicline                                       - warfarin pharmacogenetic testing 32(3)
- Champix - smoking cessation (New drug)              76-80                                        Z
    31(1) 24-7                                    Volibris
- - letters 31(5) 115-8; 31(3) 60-2               - see ambrisentan 33(1) 22-7
                                                                                                   Zavesca
- and psychiatric symptoms - Medicines            Voluven
                                                                                                   - see miglustat 33(4) 131; 33(3) 89-95
    Safety Update 33(4) 120-3                     - see pentastarch 30(4) 107-11
                                                                                                   Zeldox
varicella vaccine                                 vomiting
                                                                                                   - see ziprasidone 30(3) 59-63; 30(2) 50-5
- vaccination (letter) 30(5) 116                  - fosaprepitant - cancer chemotherapy -
                                                                                                   Zemplar
vascular endothelial growth factor                    Emend IV (New drug) 31(4) 108-11
                                                                                                   - see paricalcitol 31(4) 108-11
- angiogenesis inhibitors in cancer 29(1)         Votrient
                                                                                                   ziprasidone
    9-12                                          - see pazopanib 33(6) 193-8
                                                                                                   - schizophrenia and bipolar I disorder -
vasoconstrictors                                  vulvovaginitis
                                                                                                       Zeldox (New drug) 30(2) 50-5
- interactions with psychotropic drugs and        - butoconazole nitrate - candidal
                                                                                                   - - letter 30(3) 59-63
    dentistry 30(4) 98-101                            vulvovaginitis - Gynazole (New drug)
                                                                                                   zolpidem
vasodilators                                          29(5) 138-43
                                                                                                   - adverse effects in insomnia 31(6) 146-9
- cilostazol - intermittent claudication -
                                                                                                   zopiclone
    Pletal (New drug) 32(3) 82-6                  W                                                - adverse effects in insomnia 31(6) 146-9
- nitric oxide - neonatal respiratory failure -
                                                                                                   Zorac
    INOmax (New drug) 31(1) 24-7
                                                  wall chart                                       - see tazarotene 29(3) 84-7
Vectibix
                                                  - anaphylaxis 30(5) 115                          Zostavax
- see panitumumab 31(5) 136-9
                                                  warfarin                                         - see zoster virus vaccine 31(1) 24-7
vecuronium
                                                  - bioequivalence of Marevan and Coumadin         zoster virus vaccine
- sugammadex - reversal of neuromuscular
                                                      (letters) 30(2) 32-4                         - Zostavax (New drug) 31(1) 24-7
    blockade - Bridion (New drug) 32(3) 82-6
                                                  - interactions with fenofibrate 29(6) 166
Velcade
                                                  - - letter 30(2) 32-4
- see bortezomib 29(3) 84-7
                                                  - pharmacogenetic testing 32(3) 76-80
venlafaxine
                                                  - - dental notes 32(3) 80
- patent expiry and new drug approvals
                                                  - - letter 32(5) 119-121
    (PBAC question) 32(3) 63
                                                  - point-of-care testing (letter) 33(6) 167-170
venomous fish
                                                  whooping cough - see pertussis
- management of puncture injuries 30(5)
                                                  wilderness medicine
    117-21
                                                  - book review - Therapeutic Guidelines:
- - letter 31(2) 32
                                                      Toxicology & Wilderness 31(6) 164-5




                                                                       -25-
Author Index
Abbott PV 30(3) 77-9         Cleland LG 29(4) 90-1               Gillman K 29(4) 91-3
Abramson M 30(3) 64-7        Coates H 31(2) 40-1                 Glasgow N 30(3) 64-7
Adams J 29(1) 2-3            Collignon P 33(2) 30-1              Goergen S 33(3) 64-7
Adsett M 31(1) 21            Colquhoun D 31(5) 119-22            Goh SL 33(2) 32-3
Al-Sohaily S 31(1) 5-7       Commens C 30(6) 140-1; 29(4)        Goldman GS 30(5) 116
Albert E 31(6) 164-5            91-3                             Goldney RD 29(2) 32-5
Allison R 33(3) 64-7         Condoleon A 33(5) 145-6             Goss AN 30(4) 96-7; 30(1) 3-4
Ames D 29(3) 59-62           Cook J 33(4) 120-3; 33(3) 80-3      Graham GG 30(3) 59-63; 30(2)
Amirthanandan S 32(5) 139    Corkeron M 31(2) 32-32                 32-4
Anderson EA 30(1) 25-6       Corte C 33(4) 116-9                 Graudins LV 32(3) 61-3
Annetts P 30(3) 83           Coward M 33(2) 32-3                 Greenberg P 31(1) 10-1
Arnold T 31(1) 3-4           Cox I 31(6) 143-5                   Guirguis A 33(3) 76-9
Aslani P 30(5) 122-4         Cranswick N 32(5) 122-4; 29(3)      Gullotta J 30(4) 88-90
Backhouse P 30(4) 96-7          83                               Hague WM 30(3) 68-9
Baird A 30(6) 143-6          Crawford G 29(3) 79                 Harman J 31(6) 150-3
Baird H 32(6) 150-1          Crossing S 31(2) 32-32              Harvey KJ 31(6) 142-3; 30(2)
Balassa J 29(6) 153          Crouch AM 32(1) 9-12                   32-4
Barber N 32(5) 118-9         Crowhurst JA 32(3) 60               Haw C 29(3) 59-62
Barnes D 29(6) 159-61        Dallimore K 29(2) 52-3              Hayhow BD 29(5) 122-4
Bateman GA 31(1) 18-20       Daly CG 32(3) 72-5                  Headrick S 31(1) 21
Batey R 29(2) 36-9           Darby I 29(6) 154-5                 Healy DL 32(6) 152-4
Bayly P 31(4) 88-9           Davoren P 31(6) 159-61              Heffer R 30(1) 3-4
Beggs S 31(3) 63-5           Day RO 30(3) 59-63; 30(2) 32-4;     Helme RD 29(3) 72-5
Bell SJ 32(4) 99-104            29(6) 146-8                      Herriot P 29(5) 121
Bellchambers H 30(1) 2-3     Deans K 31(3) 60-2                  Hill C 29(3) 67-70
Bereznicki L 33(6) 167-170   DeWitt DE 31(4) 86-7                Hill CL 31(3) 60-2
Berk M 31(3) 73-6            Donovan PJ 33(5) 141-4              Hilmer SN 31(1) 2-3; 29(3) 58-9
Bickle K 33(3) 64-7          Doogue M 32(5) 119-121              Ho J 30(6) 147-9
Blake G 31(3) 76             Douglas R 29(6) 149-50              Honson K 29(3) 59-62
Boothe K 33(1) 2-4           Dowden JS 33(1) 9; 32(1) 13;        Hope J 30(2) 44-6
Bowen K 30(1) 21-4              30(6) 154; 30(4) 91; 29(5)       Horowitz JD 31(5) 115-8
Bowman D 33(4) 101-2            120; 29(1) 25                    Horvath N 32(4) 95-8
Bownas T 29(2) 32-5          Drummer OH 31(2) 33-5               Hourigan L 29(5) 134-8
Boyd B 31(1) 3-4             Dugdale P 30(2) 35-7                Howell C 30(4) 105-6
Boyd M 31(3) 66-9            Duggan A 31(1) 5-7                  Hsu DC 32(3) 68-71
Brighton T 33(2) 38-41       Duggan K 32(5) 135-8; 31(6)         Huang N 31(6) 150-3
Brodaty H 29(3) 59-62           150-3                            Hunt J 29(6) 149-50
Broom J 29(1) 6-8            Dunlop C 32(5) 138                  Iannuzzi A 30(2) 46-46
Brown L 33(3) 64-7           Dwyer DE 32(3) 64-7                 Inglis TJ 32(3) 58-9
Brown N 33(3) 72-5           Dwyer S 30(3) 73                    Isbister GK 30(5) 117-21; 29(6)
Buchan H 30(5) 114-5         Edwards R 33(4) 99-100                 156-8; 29(5) 125-9
Buckley N 29(4) 109-11       Eisman JA 33(4) 103-6               Jackson SL 33(6) 167-170; 29(5)
Buist A 31(2) 36-9           Elijah J 33(4) 120-3                   121
Burrows GD 30(4) 86-8        Elsik M 30(1) 5-7; 29(4) 93         James H 29(3) 59-62
Cai FZJ 29(4) 90-1           Farah CS 32(6) 162-4; 30(4) 106     James MJ 29(4) 90-1
Cameron C 29(3) 71           Faull R 30(1) 17-20                 Jankovic S 33(3) 64-7
Campagnaro R 31(5) 115-8     Faunce T 30(6) 138-40               Jenkins C 29(3) 63-6
Campbell DJ 32(5) 132-5      Feldschuh M 31(2) 30-1              Jeyasingham MS 33(5) 134-5
Campbell G 33(6) 167-170     Firkin F 32(6) 148-50; 32(4) 92-4   Johnson C 32(2) 42
Campbell TJ 33(3) 62-3       Fois RA 31(5) 115-8                 Johnson D 31(6) 143-5
Canny L 30(3) 59-63          Folic M 33(3) 64-7                  Johnson DW 31(6) 154-8; 30(2)
Carbonara S 31(1) 3-4        Foo H 32(3) 64-7                       32-4
Carter A 30(4) 102-5         Foran T 33(6) 171-5                 Jones G 30(2) 32-4
Cartwright K 30(5) 128-9     Foster J 31(3) 60-2                 Joshi D 33(4) 103-6
Casey J 30(4) 91             French J 30(3) 59-63                Katelaris C 32(5) 125-8; 32(3)
Caterson ID 29(2) 43-7       Fung A 33(3) 88-9                      68-71; 31(1) 8-10; 30(1) 25-6
Chaar B 33(5) 155            Gaetani L 29(5) 121                 Katz I 31(3) 60-2
Chang A 32(2) 36-8           Gallego G 30(3) 59-63               Kault D 30(4) 88-90
Cheah C 31(4) 97-97          Gallus AS 33(2) 42-7                Kaye K 29(6) 146-8
Cheng A 29(1) 3-5            Ghiculescu RA 31(2) 42-4; 29(6)     Keks NA 30(2) 44-6
Choo C 31(1) 10-1               166                              Kennedy D 30(6) 162-3
Clarke S 29(1) 9-12          Gibbs H 30(2) 38-40                 Kennedy MA 30(6) 140-1




                                                 -26-
Kerridge I 29(3) 76-9              McGuire TM 33(6) 177-80;           Raven M 31(5) 115-8
Khalil H 33(5) 144                    33(5) 147-9; 33(1) 5-5; 30(1)   Ravi Kumar A 31(5) 123-8
Khan SA 29(3) 59-62                   14-6                            Reath J 33(3) 72-5
Koh C 32(6) 151                    McIntosh L 32(6) 162-4             Reddel SW 30(6) 156-60
Komesaroff PA 30(6) 150-3          McIntyre HD 33(5) 141-4            Reeves G 30(3) 74-6
Konstantinos A 33(1) 12-18         McKinnon RA 32(6) 146-7            Reutens AT 31(4) 104-8
Kopp C 29(3) 59-62                 McLachlan AJ 33(3) 62-3; 31(5)     Rigby D 33(6) 191-3
Kostov SH 32(1) 5                     115-8; 30(2) 41-3; 29(2) 40-2   Riminton S 29(5) 130-3
Krum H 30(1) 5-7; 29(2) 32-5       McLaughlan R 32(3) 60              Roberts DM 33(2) 34-7
Kubler P 32(2) 32-5; 29(6)         McLean A 31(3) 77-9                Roberts LJ 31(5) 133-5
   148-9; 29(5) 124                McMillan M 30(1) 2-3               Robinson J 29(3) 83
Kuteesa W 29(1) 22-4               Mewes BT 31(5) 115-8               Rodrigues G 29(3) 59-62
Kyle G 33(6) 166-7                 Milne RW 30(2) 41-3                Roger SD 32(5) 129-131
Ladhams B 31(4) 97-97              Milovanovic D 33(3) 64-7           Romas E 31(2) 45-9
Lake P 29(3) 59-62                 Miners J 32(5) 119-121             Rout J 33(3) 64-7
Landau J 31(1) 10-1                Mitchell PB 30(3) 70-3             Rowles G 33(3) 64-7
Lander C 31(1) 21                  Montanari A 31(6) 143-5; 31(3)     Sanati S 33(5) 137
Lander CM 31(3) 70-2                  60-2                            Scheinberg A 32(2) 39-42
Langguth D 29(6) 162-4             Moore KH 29(1) 22-4                Scott I 31(1) 12-6
Latham M 30(6) 161                 Morgan S 33(1) 2-4                 Seale P 33(6) 167-170
Leach AJ 32(6) 155-9               Moro P 30(3) 59-63                 Segelov E 29(1) 2-3
Lee L 30(1) 17-20                  Morris PS 32(6) 155-9              Selby W 33(4) 116-9
Leong A 31(6) 143-5                Mortimer R 33(3) 64-7              Senanayake S 32(5) 140
Leong J 33(4) 101-2                Moses GM 33(6) 177-80              Sharma R 29(1) 9-12
Lewis T 30(6) 140-1                Moulds RFW 33(5) 134-5             Shaw JE 31(4) 104-8
Lim EM 32(1) 19-21                 Murney P 31(4) 98-101              Sheehy K 33(3) 64-7
Limaye S 33(3) 84-7                Murnion BP 33(4) 113-5             Shenfield GM 31(3) 58-9
Litt J 31(5) 115-8                 Murtagh JE 29(4) 94-6              Shephard M 33(1) 6-9
Liu C 31(6) 158                    Nandurkar H 32(6) 148-50           Siderov J 32(3) 60; 30(1) 24-5
Lofgren H 30(6) 138-40             Nash P 31(3) 60-2                  Siebert D 30(2) 30-1
Lopert R 32(4) 90-1                Neeskens P 30(2) 47-50             Simpson G 32(4) 105-7
Lowe J 33(5) 138-40                Nelson M 33(4) 108-12              Singer RF 33(2) 34-7
Lowe MP 29(5) 122-4                Ng CS 30(3) 67                     Singh A 31(3) 73-6
Lowinger JS 32(4) 108-12           Nguyen T 32(4) 99-104              Sloss A 32(2) 32-5
Lowy AJ 31(3) 60-2                 Nissen L 33(6) 166-7               Smith AJ 30(3) 58-9
Lu CY 32(6) 146-7; 29(6) 146-8     Ogle SJ 29(3) 58-9                 Smith RL 29(1) 18-21
Lu K 31(1) 10-1                    Olson LG 31(6) 146-9               Smith WB 32(5) 125-8; 31(1)
Lu TYT 29(3) 67-70                 Olver I 29(4) 97-8                    8-10
Lynch K 33(2) 32-3                 Olver JS 30(4) 86-8                Somerville-Brown LM 30(4)
MacPherson R 31(4) 88-9            Ooi C 30(1) 8-13                      98-101
Mainwaring P 29(1) 13-5            Osborn M 32(4) 95-8                Somogyi A 32(5) 119-121; 32(5)
Mangin D 29(2) 30-2                Page MM 30(4) 98-101                  119-121; 29(6) 149-50
Mansfield PR 33(4) 98-9            Pain MCF 29(3) 70                  Soyer HP 33(5) 150-5
Marchant J 32(2) 36-8              Park KEJ 32(2) 30-1                Stafford L 33(6) 167-170
Martin J 31(6) 143-5               Patounas MP 33(5) 147-9; 33(1)     Steiner M 31(1) 16-7
Martin JH 32(5) 119-121; 32(3)        5-5; 30(1) 14-6                 Stockigt JR 29(2) 32-5; 29(1) 3-5
   76-80                           Pavlakis N 29(6) 151-3             Sullivan JR 32(1) 14-8
Masarei J 32(5) 119-121            Pearce G 33(5) 145-6; 30(4)        Sung V 32(5) 122-4
Mathew T 30(2) 32-4                   88-90                           Sutherland B 32(3) 63
Maxwell DJ 32(4) 108-12            Penny B 30(5) 130-3                Sved Williams A 30(5) 125-7
May K 31(4) 94-6                   Peterson GM 33(6) 167-170;         Swaminathan S 29(5) 130-3
McCann A 30(4) 92-6                   29(5) 121                       Sweet M 33(5) 136-7; 32(1) 2-4
McCluskey PJ 33(3) 88-9            Pett S 31(3) 66-9                  Tan KS 31(6) 154-8
McCormack D 29(4) 109-11           Phillips P 32(2) 43-6              Tatchell M 32(1) 6-8
McCullough M 33(6) 181; 33(4)      Pillans P 29(4) 99-101             Taverner D 29(5) 121
   107; 33(3) 71; 32(6) 162-4;     Porter R 33(2) 32-3                Taylor T 29(6) 149-50
   32(3) 75; 32(3) 80; 32(1) 18;   Preda VA 32(1) 14-8                Thomas B 29(5) 121
   31(6) 153; 31(5) 136; 30(6)     Prins JB 31(4) 102-4               Thomson KR 33(1) 19-22
   146; 30(6) 153; 30(6) 160;      Prior F 31(2) 32-32                Thyagarajan D 31(4) 90-3
   30(2) 37-37; 30(2) 43-43;       Pyle DI 30(3) 70-3                 To LB 32(4) 95-8
   30(1) 13; 29(4) 108; 29(4)      Ragg M 31(3) 60-2                  Tompson A 29(5) 121
   108; 29(3) 82; 29(2) 52         Ramzan I 31(5) 115-8; 30(2)        Tong WWY 30(1) 25-6
McDonald C 30(3) 64-7                 41-3; 29(2) 40-2                Toop L 29(2) 30-2
McGuinness R 31(4) 88-9            Raven JL 33(6) 167-170             Torpy DJ 30(6) 147-9




                                                       -27-
Tran HA 29(2) 48-52
Trevillian P 29(4) 102-8
Turner MB 33(2) 48-51
Turnidge J 33(3) 68-71
Twaddell S 33(2) 47; 32(2) 47-50
Van Gool K 30(3) 59-63
van Tienen E 33(6) 167-170
Vance A 31(5) 129-32
Vanlint S 31(2) 39
Vardy J 31(1) 22-4
Varma DK 33(1) 19-22
Verma AK 33(4) 124-9
Vicaretti M 33(6) 186-90
Vitry A 31(5) 114-5
Vivian D 30(3) 59-63
Walker JB 32(2) 31; 30(4) 88-90
Walsh JF 33(6) 167-170; 30(1)
   3-4
Walters S 30(2) 32-4
Ward M 33(3) 80-3
Wark PAB 29(5) 118-9
Watterson J 33(6) 167-170
Weatherill C 29(4) 91-3
Weerasuriya K 29(2) 32-5
Weitzel P 32(5) 119-121
Westbury J 31(1) 3-4
Wilcox RA 29(1) 21
Williams K 30(2) 32-4
Wodak A 29(1) 8
Wong RCW 29(6) 162-4
Wood E 33(3) 76-9
Wood ML 29(1) 6-8
Wu J 30(4) 102-5
Wurm EM 33(5) 150-5
Zaninovich L 30(5) 116
Zecevic DR 33(3) 64-7
Zwar N 29(3) 80-2




                                   -28-

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:69
posted:7/26/2011
language:English
pages:28